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GENERAL INTRODUCTION 
The human brain, which consists of about 10^^ nerve cells and 10^2 gijai cells, 
continually receives information, elaborates and perceives it, and makes 
decisions. To carry out this task, the nervous system possesses an immense 
nim\ber of lines of communication provided by the nerve cells (neurons). Each 
neuron makes specific contact with many target cells such as different tj^es of 
neurons, gland cells, or muscle cells. 
In order for neurons to communicate with each other, they need to have 
points of "contact" with each other. These are called synapses, named by the 
English physiologist Charles Sherrington in 1897. The term synapse is derived 
from the Greek, meaning to clasp, connect or join. Sherrington thought of it, 
anatomically as a site of "surfaces of separation", but he always emphasized that 
it was first and foremost afunctional connection. In 1911, Ram6n y Cajal foimd 
that there were three elements for a s5mapse: a presynaptic terminal, a 
postsynaptic target site and the synaptic cleft, the space between the pre- and 
post-synaptic plasma membranes. These three elements underline the ability of 
neurons to communicate with one another, the process of synaptic transmission. 
Literature Review 
Synaptic Vesicle and Neurotransmitter Release 
It has been widely accepted that there are two major modes of synaptic 
transmission: electrical, which depends on current through gap junctions that 
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bridge the cytoplasm of pre- and post-synaptic cells (Furshpan and Potter, 1957; 
reviewed by Bennett et al., 1991); and chemical, in which pre- and post-synaptic 
cells have no direct continuity (Katz, 1966; Changeux, 1981; Karlin, 1990), 
Synaptic transmission across the majority of synapses in the brain is mediated by 
the interaction of chemical signals released from the presynaptic terminal with 
postsynaptic receptors (reviewed by Jessell and Kandel, 1993). 
In the resting state, neurotransmitters such as glutamate, y-aminobutyric acid 
(GABA) and acetylcholine (ACh) are stored in uniformly sized small organelles 
of 40-50 nm diameter. When an action potential reaches the nerve terminal, the 
presynaptic plasma membrane depolarizes and voltage-gated calcium channels 
open at the active zone. The ensuing rise in intracellular calcium triggers 
exocytosis of synaptic vesicles, resulting in the release of the neurotransmitter 
(Katz, 1966). The synaptic vesicle membranes are reclaimed from the plasma 
membrane by endocytosis, and the vesicles eventually refill with 
neurotransmitter (Siidhof and Reinhard, 1991). To summarize this process, Kelly 
(1993) indicates that transmitter release can be considered to involve at least four 
steps: the transport of vesicles from the reserve pool to the releasable pool at the 
active zones, the docking of vesicles to their release sites at the active zones, the 
fusion of the synaptic vesicle membrane with the plasma membrane during 
exocytosis in response to an increase in intracellular Ca2+, and the retrieval and 
the recycling of vesicle membrane following exocytosis. 
Synaptic vesicles have two fundamentally different functions: they take up 
and store neurotransmitters, and they fuse with and bud from other membranes, 
most notably the presynaptic plasma membrane. These functions must be 
performed by the proteins of synaptic vesicles, either alone or in concert with 
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other components of the nerve terminal. A major advance in the analysis of 
transmitter release mechanisms has been the cloning and characterization of 
several proteins that may participate in different aspects of the release cycle. As 
might be expected from the steps involved in release, these proteins fall into four 
groups: proteins such as the synapsins that are thought to control the 
mobilization of vesicles and thereby to regulate their availability for release (De 
Camilli et al, 1990); proteins such as Raba, a member of the p21ras superfamily, 
thought to be involved in the intracellular trafficking and docking of sjmaptic 
vesicles (Zahraoui et al., 1989); proteins such as synaptotagmin, synaptobrevin, 
neurexins, and sjmtaxins, which appear to be involved more specifically in 
docking vesicles into release sites on the presynaptic membrane (Bennett et al., 
1991; Trimble et al., 1991; Schiavo et al., 1992); and proteins such as 
synaptophysin, thought to be involved in the formation of the vesicle fusion pore 
or in recycling (Aimers and Tse, 1990; Siidhof and Jahn, 1991; White, 1992). 
The Central Role of in Neurotransmitter Release 
As mentioned above, the elevation of the intracellular calcium level 
following calcium influx through voltage-gated calcium channels is a critical step 
in action potential evoked synaptic transmission (Augustine et al., 1987). 
However, in a number of experimental conditions neurotransmitter can also be 
released in the absence of extracellular calcium (Adam-Vizi et al., 1984; Hochner 
et al., 1989). Neurotransmitter release in the absence of calcium may be derived 
from a different intracellular pool than that in the presence of calcium (Adam-
Vizi et al, 1990). The concentration of calcium in the nerve terminal is controlled 
by a complex system of soluble buffers, organellar stores and a membrane 
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transport system with varying calcium transport affinities and capacities; 
distortion will result in a modulation of transmitter release (Adam-Vizi and 
Ashley, 1987). Calcium is sequestered inside the nerve terminal in the smooth 
endoplasmic reticulum, synaptic vesicles, mitochondria, and possibly also 
caldsomes. Furthermore, there exist intracellular buffering systems like calcium-
binding proteins (Blaustein, 1988; Meldolesi, 1988). 
Inositol polyphosphates have been assigned a key role in calcium 
intracellular homeostasis. Inositol 1,4,5-trisphosphate (IP3) is formed by receptor-
mediated and G-protein-controlled turnover of phosphatidylinositol 4,5-
bisphosphate together with diacylglycerol (DAG), an activator of protein kinase 
C (PKC). The inositol trisphosphate functions via specific receptors in the release 
of caldimi from intracellular stores, presumably the endoplasmic reticulum and 
the caldsome (Nahorski, 1988). In addition to the IPs-sensitive pool, there is an 
IPs-insensitive calcium store, which is located in the peripheral region of the cell 
away from the nucleus (Hardie, 1991). Caldum in the IPs-insensitive pool can be 
released by the drug caffeine, which also activates the Ca2+-release channels of 
sarcoplasmic reticulum (ryanodine receptors). It is believed that, in axon 
terminals, receptor-mediated turnover of synaptic phosphoinositides for 
mobilizing calcium from internal stores may serve mainly as a modulatory 
mechanism. 
Mechanisms of Glutamate Release 
It is well established that glutamate and aspartate mediate the excitatory 
transactions taking place between nerve cells in the vertebrate central nervous 
system (QMS). Glutamate is probably the main excitatory amino acid (EAA) 
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neurotransmitter in the mammalian CNS. It works along with other acidic amino 
adds, particularly aspartate, homocysteate and cysteine sulfinate (Mayer and 
Westbook, 1987). Since the first proposal of the vesicular hypothesis more than 30 
years ago (Del Castillo and Katz, 1957), the release of numerous 
neurotransmitters has been assumed to be due to the exocytosis of synaptic 
vesicles in response to an increase in the cytoplasmic calcium concentration in 
nerve terminals. Many arguments favor such a release mechanism for glutamate. 
These include the calcium dependency of glutamate release (Nicholls and Sihra, 
1986), the presence of glutamate-like compounds in synaptic vesicles (Stom-
Mathisen et al., 1983), and the massive and rapid accumulation of glutamate in 
highly purified synaptic vesicles (Naito and Ueda, 1983,1985). 
However, glutamate is transported by a reversible, sodium dependent 
(Kanner and Sharon, 1978; Kanner and Marva, 1982; Erecinska et al., 1983,1987; 
Wilson and Pastuszko, 1986), and electrogenic (Brew and Attwell, 1987; 
Szatkowski et al., 1990) uptake mechanism, so it remains possible that the 
reversal of the EAA uptake system could account, at least in part, for the release 
of EAAs. Such a mechanism may explain the calcium independent EAA release 
reported, for example, in the retina (Miller and Schwartz, 1983). 
There is the third situation for the accumulation of extracellular glutamate. 
Swelling of isolated cells and many vertebrate and invertebrate tissues leads to 
release of glutamate, aspartate, taurine, and other amino acids (Kimelberg and 
Ransom, 1986). This release is part of the process of regulatory volume decrease 
by which swollen cells regain their normal volume (Gilles et al., 1987). Swelling-
induced release of glutamate is inhibited by a number of anion transport blockers 
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such as furosemide and L-644,711, a fluorenyl derivative of ethacrynic add 
(Kimelberg et al., 1987). 
Types of Glutamate Receptors 
Glutamate interacts with at least five classes of membrane receptors, each 
with significantly distinct functions (reviewed by Monaghan, 1989). Three have 
been defined by the depolarizing actions of selective agonists (N-methyl-D-
Aspartate, NMD A; kainate; quisqualate or a-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid, AMP A) and their blockade by selective 
antagonists (Watkins and Olverman, 1987). A fourth, the AP4 receptor (L-2-
amino-4-phosphonobutyrate) appears to represent an inhibitory autoreceptor 
(Koemer and Cotman, 1981; Davies and Watkins, 1982; Evans et al., 1982). The 
fifth receptor, activated by trans-l-aminocyclopentane-l,3-dicarboxylic acid 
(ACPD), modifies inositol phosphate metabolism (Baudry et al., 1986; Nicoletti et 
al., 1986; Sladeczek et al, 1985). 
The NMDA receptor is best defined. This receptor opens a distinctive 
membrane channel characterized by high conductance (main state about 50 pS), 
voltage-dependent Mg2+ blockade and permeability to both and Na+ (Nicoll 
et al., 1988; Ascher and Nowak, 1988; MacDermott and Dale, 1987; Mayer and 
Westbrook, 1987). Voltage-clamp studies of cultured neurons injected with a 
calcium-sensitive dye indicate that Ca2+ can enter cells after NMDA application 
in a manner independent of the voltage-dependent calcium channels 
(MacDermott et al., 1987; Mayer et al., 1987). The increase in intracellular Ca2+ 
ions is thought to initiate the biochemical processes responsible for both NMDA 
receptor-induced plasticity observed in developing and adult animals (Lynch et 
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al., 1983; Collingridge et al., 1987; Cotman et al., 1988) and NMDA receptor-
mediated excitotoxic cell death (Rothman and Olney, 1986; Cotman et al., 1988). 
Although NMDA receptors play a critical role in synaptic function, they do 
not mediate the excitatory postsynaptic potential resulting from a unitary 
synaptic activation. Pharmacological studies indicate that kainate and/or 
quisqualate receptors are responsible for the voltage-independent portion of the 
synaptic response in many neuronal pathways (reviewed by Mayer and 
Westbrook, 1987; Watkins and Evans, 1981), The kainate/quisqualate antagonist, 
6-cyano-7-nitroquinoxaline-2,3-done (CNQX), blocks synaptic transmission at 
low concentration (Honors et al., 1988; Blake et al., 1988). 
Glutamate-induced excitatory transmission appears to involve actions 
mediated by one or more combination of glutamate receptors. 
Neuroglia 
Glial cells are intimately associated with most neurons. The neuroglial cells 
used to be called arachnoid cells because of their resemblance to spiders. They 
were also described as Deiter's cells in honor of the researcher who discovered 
them. The main classes of glial cells in the vertebrate central nervous system are 
astrocytes, oligodendrocytes and microglia, whereas Schwann cells are the 
predominant glial type in the peripheral nervous system. 
Neurobiologists have wondered for 150 years what glial cells do. There were 
several hypotheses about the functions of neuroglial cells. One of them was 
Golgi's nutritive theory. This theory was based on the fact that the dendrites of 
neurons are in contact with the capillaries or with neuroglial cells. The 
capillaries, neuroglial cells and dendrites thus form a solid functional unit the 
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role of which is to carry to the cell body of neurons the nutritive elements that 
are necessary for it. The second hjqjothesis was Weigert's "filling-out" theory that 
the role of neuroglia is simply passive, to fill out the empty spaces left by the 
neuronal elements. The third one was the isolation theory favored by Cajal. He 
proposed that neuroglial cells form a resistance field of passage for nerve 
conduction. 
Although there are still different hypotheses about the physiological roles of 
neuroglial cells, it has been widely accepted that neuroglia serve as supporting 
and protective material to the neurons and to the capillary blood vessels. 
However, recent findings suggest that glial cells may be more actively involved 
in brain function than had been previously thought. New studies, made possible 
with patch-clamp recording, have shown that glial cells in vitro and in situ 
possess most of the same kinds of voltage-dependent ion channels that are found 
in neurons (reviewed in Barres et al., 1990; Bevan, 1990). Glial cells in culture 
respond to a variety of neurotransmitters with changes in membrane potential 
(reviewed by Bevan, 1990). Electrophysiological studies show that cultured glial 
cells are indeed depolarized by glutamate (Kettenman et al., 1984a; Browman 
and Kimelberg, 1984; Kettenmanne et al., 1984b). 
The glial membrane is sensitive not only to glutamate but also to some of the 
glutamate analogs used to define the subtypes of neuronal glutamate receptors. 
Cultured glia are depolarized by kainate which acts on kainate receptors, and 
they are also depolarized by quisqualate and AMP A, which are selective agonists 
of neuronal quisqualate-AMPA receptors (Teichberg, 1991). As a general rule, 
NMDA and other agonists acting at neuronal NMDA receptors do not depolarize 
the glial membrane (Backus et al., 1989; Usowicz et al., 1989; Barres et al., 1990b). 
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The presence of glutamate receptors on glia suggests that signaling via 
glutamate between neurons and glia might occur. In support of this theory, squid 
giant axons have been found to signal their Schwann cells (Lieberman et al., 1989; 
Lieberman, 1991). The other example of neuron to glial signaling mediated by 
neurotransmitters has been studied in the mammalian brain slice preparation 
(Dani et al., 1990). Calcium waves in astrocytes can be elicited by the application 
of NMDA in an organotj^ic hippocampal slice preparation. Since the astrocytes 
are believed to express only non-NMDA receptors, the calcium waves are most 
likely induced by an NMDA-evoked glutamate release from neurons. 
Glia-neuron Signaling 
Can glial cells signal neurons? Glial cells synthesize and, in some cases, 
release neurotransmitters. Schwann cells of the squid giant axon normally 
synthesize and release ACh (Heumann et al., 1981). The neurotransmitter GABA 
can be detected, using HPLC (high-pressure liquid chromatography), in 02A 
glial cells cultured in medium lacking any source of GABA (Barres et al, 1990b). 
Astrocytes have been shown to directly modulate the free cytosolic calcium and 
signal their neighboring neurons through intercellular connections (Nedergaard, 
1994). 
Electrogenic glutamate uptake is a commonly occurring system on glia and a 
major current carrier. Its likely functions are to terminate the transmitter action of 
glutamate and to prevent it from exerting its neurotoxic properties. It may also 
play a role in S)maptic plasticity (Barbour et al., 1989). Although it has been 
suggested that glutamate release from glia is by "reversed uptake" in special 
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experimental conditions (Schwartz, 1987)., there is not yet convincing evidence to 
show the mechanism of glutamate release from glia. 
Neuioligands 
The research described in this thesis focused on the effects of neurohgand 
capsaicin on cultured peptidergic sensory neurons and the mechanism of 
neuroligand bradykinin- and adenosine 5'-triphosphate-induced release of 
glutamate from glial cultures. 
CAPSAICIN Capsaicin (8-methyl-N-vanillyl-6-nonemamide), the pungent 
ingredient found in peppers of the capsicum family, has a variety of effects on 
the C-type sensory neurons responsible for the transmission of nociceptive 
information (Fitzgerald, 1983). The "hot" sensation caused by peppers is due to 
excitation of afferent nerve endings in the oral cavity by capsaicin. Similar 
excitatory actions occur in the skin, in the airways and in many visceral organs. 
This widespread irritancy is due to highly selective excitation of a sub-class of 
somatovisceral afferents with unmyelinated axons. Capsaicin selectively 
depolarizes dorsal root ganglion (DRG) neurons and excites nociceptive primary 
afferents (Heyman and Rang, 1985). The depolarization produced by capsaicin is 
due to a non-specific permeability increase for sodium and calcium (Marsh et 
al.; 1987, Wood et al., 1988). The C-type sensory neurons activated by capsaicin 
contain substance P (SP) and calcitonin gene-related peptide (CGRP) and 
participate in pain perception, thermoregulation and in neurogenic inflammation 
(Holzer, 1988). In neonatal rats and mice, the systemic injection of capsaicin leads 
to large reductions in numbers of C-fibers and DRG neuronal cell bodies (Buck 
and Burks, 1986; Holzer et al., 1988). Levels of all peptides found in small afferent 
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neurons supplying somatic and visceral tissues are reduced by capsaicin 
treatment (Jessell et al., 1978). Although many experiments have been done with 
capsaicin, it is unclear how capsaicin can stimulate the transmission of 
nociceptive information. In the first paper of this thesis, we determined the 
effects of capsaicin on peptidergic neurons in cultures. 
BRADYKININ (BK) The neuroligand bradykinin is a potent inflammatory 
nonapeptide (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) whose generation in 
tissues and body fluids elicits numerous responses including vasodilation, 
edema, smooth muscle spasm, as well as pain and hyperalgesia via stimulation 
of C- and A3-fibers. There is substantial evidence that BK contributes to the 
inflammatory response in acute and chronic diseases including allergic reaction, 
arthritis, asthma, sepsis, viral rhinitis, and inflammatory bowel diseases. There 
are at least two types of BK receptor, Bi and B2. The Bi receptor is not expressed 
to any significant extent in normal tissues. It may be of greater significance in 
pathophysiological conditions. Most action of BK is mediated through the B2 
receptor (Dray, 1993). BK produces an immediate depolarization of sensory 
neurons and nociceptive fibers (Dray and Perkins, 1993). It also stimulates 
membrane phospholipase C (PLC) to generate IP3 and DAG which elevate 
intracellular calcium and activate intracellular PKC, respectively (Burgess et al., 
1989; McGuirk and Dolphin, 1992). 
The objectives of the second paper in this thesis were to determine whether 
bradykinin can induce release of EAAs from cultured Schwarm cells and the 
mechanism of bradykinin-mediated EAA release from Schwann cells. 
Furthermore, in the fourth paper, we demonstrated that the release of the 
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excitatory amino add glutamate from astrocytes plays an important role in 
astrocyte-neuron signalling. 
ADENOSINE 5'-TRIPHOSPHATE (ATP) The significance of intracellular 
ATP has been recognized for a long time, but it is only recently that an 
extracellular role for this nucleotide has been accepted. It has been demonstrated 
that micromolar concentrations of ATP affect several biological processes 
including neurotransmission (peripheral and central), cardiac function, muscle 
contraction and relaxation, platelet aggregation, vascular tone, secretion of 
hormones and other factors, immune responses and cell growth (reviewed by 
Gordon, 1986; Bumstock, 1990). Of particular interest is the finding that ATP can 
be released from neurons and may be an important chemical mediator of 
s)maptic transmission in the central nervous system (White, 1977; Richardson 
and Brown, 1987; Wieraszko et al.,1989). Although calcium as a second 
messenger plays an important role in a number of signal transduction-regulated 
functions in neurons (Miller, 1987), relatively little is known about signaling in 
glia and the processes that are influenced by increases in intracellular calcium in 
these cells. The purpose of the third study in this thesis was to determine 
whether ATP induces the release of EAAs from cultured glia and whether 
caldam is involved in the ATP-induced EAA release. 
Significance of Research 
As we know, the release of excitatory amino acids from nerve terminals plays 
an important role in synaptic transmission. Increasing extracellular glutamate 
and aspartate are likely to modulate neuronal properties such as learning and 
memory, developmental plasticity and epileptogenesis. Excessive glutamate 
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release from glia may also lead to neuroi\ death or i\eurodegeneratory disorders. 
Do neuroglial cells play roles in these physiological or pathological states? The 
specific effects of excitatory amino acids released from glial cells need to be 
elucidated. 
Studying the mechanism of neuroligand-induced release of EAAs from glial 
cultures will help us to vinderstand the signal transduction pathways of the 
neurotransmitter release process in glia. By using this information and 
combining it with other research results, we may be able to prevent or attenuate 
some brain diseases in the future. 
Dissertation Organization 
This dissertation is composed of four papers. The papers are preceded by a 
general introduction and followed by a general conclusion which include a 
summary and discussion of the entire body of work. References cited in the 
general introduction and the general conclusion follow the general conclusion. 
Most of the experiments were performed in the Department of Veterinary 
Anatomy under the guidance of Dr. Srdija Jeftinija. 
The experiments involving calcium imaging (chapter 2 and chapter 4) were 
performed by Vladimir Parpura in the laboratory of Dr. Philip Haydon. 
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CHAPTER 1. EFFECT OF CAPSAICIN AND RESINIFERATOXIN ON 
PEPTIDERGIC NEURONS IN CULTURED DORSAL ROOT GANGLION 
A paper published in Regulatory Peptides 
Srdija Jeftiiuja, Fang Liu, Ksenija Jeftinija and Laszlo Urban 
Summary 
The neurotoxic effect of capsaicin has been shown to be selective on a 
subpopulation of small dorsal root ganglion neurons in newborn animals. The 
aim of this study was to provide evidence of the long lasting effect of capsaicin 
and its ultrapotent analog resiniferatoxin (RTX) on sensory peptidergic neurons 
maintained in organotypic cultures. The effects of the two irritants were 
examined on neurons that contained substance P (SP) and calcitonin gene-related 
peptide (CGRP). Exposure of the cultures to 10|iM capsaicin and lOOnM RTX for 
periods of 2 days or longer resulted in almost complete elimination of SP-
immunoreactive (IR) neurites and reduction, but not elimination, of CGRP-IR 
neurites. In addition, both 10|iM capsaicin and lOOnM RTX significantly reduced 
the number of SP- and CGRP-IR cell bodies within ORG explants. Capsaicin in 
100|iM concentration produced complete elimination of SP-IR fibers and a 
greater decrease in the number of CGRP-IR fibers, but failed to completely 
eliminate IR cell bodies. Exposure of the cultures to the irritants in the same 
concentrations for 90 min did not produce a measurable effect on SP- or CGRP-
IR in neurites or cell bodies. It is important to establish that the effect of 
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capsaicin and RTX on cultured neurons was of long duration (longer than 4 days) 
and is therefore different from depletion of peptides. 
These findings demonstrate that processes of cultured sensory neurons are 
much more sensitive to capsaicin and RTX than cell bodies. Furthermore, our 
results show that SP-IR neuronal elements are more sensitive to capsaicin than 
CGRP-IR elements. These data suggest that cultured sensory neurons express 
the functional properties of differentiated sensory neurons in vivo. 
Key words: Primary sensory neuron. Neurotoxicity, Organotypic culture. 
Substance P, Calcitonin gene-related peptide 
Introduction 
Capsaicin (8-methyl-N-vanillyl-6-nonemamide), the pungent substance found in 
plants of the capsicum family, has a variety of effects on the small unmyelinated 
and myelinated sensory neurons responsible for the transmission of nociceptive 
information [2,8]. Capsaicin selectively depolarizes dorsal root ganglion (DRG) 
neurons [18], excites nociceptive primary afferents [9], and inhibits voltage 
activated Ca2+ current by evoking intracellular Ca ion accumulation [38]. The 
C-type sensory neurons activated by capsaicin contain substance P (SP) and 
calcitonin gene-related peptide (CGRP), and participate in nociception, 
thermoregulation and in neurogenic inflammation [3,19]. Capsaicin induces 
release of CGRP and SP from both peripheral [10,11,20,37] and central 
terminals [13,14,26,27]. Capsaicin also evokes release of excitatory amino acids 
(glutamate and aspartate) from cultured DRG neurons [25]_ 
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Depletion of neuropeptides occurs after administration of higher doses of 
capsaicin to intact animals as well as after exposiu-e of isolated tissues to higher 
concentrations of capsaicin [30,36]. Depletion of releasable peptide pool or 
accumulation of toxic levels of intracellular calcium ions might be involved in the 
sensory neuron blocking and neurotoxicity of capsaicin [16,31]. Neurotoxic effect 
of capsaicin is restricted to a subpopulation of DRG neurons and is age related; 
when administered to neonatal rats, capsaicin causes a large reduction in the 
number of C-fibers and "small dark" neurons [23,24,35]. 
Resiniferatoxin (RTX) is a natural diterpen structurally related to the phorbol 
esters that is neither tumor promoting nor does it compete for binding to protein 
kinase at concentrations required for the capsaicin-like effects [7,39]. It has been 
shown that RTX mimics the effects of capsaicin in stimulating and disensitizing 
certain peptidergic unmyelinated primary afferents [6,32]. A common capsaicin-
RTX-binding site discovered by Szallasi and Blumberg [33,34] might correspond 
to the capsaicin "receptor" whose presence was predicted [22,32]. 
The aim of this study was to provide evidence on the effect of capsaicin and 
its ultrapotent analog RTX on peptidergic DRG neurons harvested from two day 
old animals and maintained in culture. By utilizing cultures we were able to 
study the effect of irritant when acting for long time, conditions similar to in vivo 
injection. In order to evaluate the irreversible effect of capsaicin and RTX we 
chose to monitor changes in SP and CGRP immunoreactivity of DRG somata 
and neurite-outgrowth of DRG neurons. 
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Materials and Methods 
Preparation of cultures 
Organotypic DRG cultures were prepared according to a modification of 
methods described by Gahwiler [12] and Delfs et al. [5]. Two day old Sprague-
Dawley rats were decapitated and following laminectomy DRGs were aseptically 
dissected out and transferred into chill Gay's balanced salt solution (BSS). 
Culturing was carried out on glass coverslips which were specially prepared by 
soaking 24 hours in xylene, 4 hours in acetone, 24 hours in absolute alcohol, and 
dried for 30 min at SQOC. Explants were placed on glass coverslips which were 
coated with chicken plasma. One drop of thrombin solution was added to keep 
explants in place. Glass coverslips with explants were placed into Petri dishes 
where the culturing medium (25% horse serum, 25% Earls BSS, 50% Basal 
Medium Eagles with glucose 6,4 mg/ml) was changed every second day. 
Cultures were kept in an incubator at 36 °C in 95% O2 and 5% CO2. 
Four exposure schedules were designed in order to study the time course of 
capsaicin or RTX's neurotoxic effect: 1) Capsaicin (10, and 100 |iM) or RTX (10 
and 100 nM) were present in the growing media for the whole culturing period. 
2) Capsaicin or RTX in the concentrations listed above were added to the culture 
on day 1 and were removed 48 hours later. The cultures were maintained for 
next 4-5 days in normal media. 3) Capsaicin or RTX (in above concentrations) 
were added to established 4 day old cultures and were present in the media for 2 
days. 4) Capsaicin or RTX (in listed concentrations) were added to newly started 
cultures or to 4 day old established cultures for 90 min and then cultures were 
kept in normal medial for the rest of culturing. 
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Stock solutions of capsaicin (8-methyl-N-vanillyl-6-noneaneamide; Sigma) 
and RTX (resiniferatoxin, Sigma) were made in ethanol or dimethylsulphoxide 
(Sigma) and diluted in appropriate growing media. 
Immunocytochemistry (ICC) 
Cultures were fixed in 4% paraformaldehyde for 1 hour. After fixation, 
cultures were washed in 50 mM potassium phosphate buffer (KPBS) and held in 
KPBS until starting ICC. The ICC procedure was performed by using a 
modification of the avidin-biotin-peroxidase complex (ABC) technique [21]. 
Cultures were washed 3 times for 10 min each in 50 mM KPBS. Inactivation of 
endogenous hydrogen peroxidase was achieved by rinsing cultures in 0.3% 
hydrogen peroxide in 50 mM KPBS for 15 min. The cultures were incubated for 
30 min in 3% normal goat serum in 50 mM KPBS, 1% bovine serum albumin 
(BSA) and 0.4% Triton X-100. SP and CGRP antiserum were diluted to 1:5000 
in 50 mM KPBS, 1% BSA and 0.4% Triton X-100. After incubation with primary 
antiserum for 24 hours at 40C (for CGRP) or at room temperature (for SP), the 
cultures were adequately washed. Following washing, the cultures were 
incubated in goat anti-rabbit IgG (Vector; 1:600) for one hour at room 
temperature and than reacted with avidin-biotin complex (Vector; 1:200) for 
additional hour at room temperature. Staining was performed by exposing 
cultiures to 0.04% 3-3'diaminobenzidine tetrahydrochloride (DAB, Sigma), 2.5% 
nickel sulfate (Fisher Scientific) and 0.01% hydrogen peroxide dissolved in O.IM 
sodium acetate. Controls were processed by omitting the specific antiserum or 
using antiserum preabsorbed with l|iM concentration of the immunogen. No 
positive immunostaining was detected on the control tissues. 
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SP-IR and CGRP-IR neurons were counted in single ganglia under the light 
microscope and averaged. Images of IR neurites were quantified by image 
analysis system (Zeiss-Kontron; IDAS version 2.00). Samples were viewed with a 
Zeiss axiophot microscope at 6.25x magnification (2.5x by 2.5x optivar). Images 
were captured with a Sony 3CCD color video camera. The internal scaling 
feature of the image analysis software was calibrated to measure in millimeters. 
The neurite images imderwent normalization (histogram stretching) and contour 
enhancement prior to interactive discrimination. The resulting images were 
measured to obtain the area of immunoreactive neurites present in the field. 
Four fields, evenly spaced around the DRG explant, were measured from each 
culture. The total area measured for each field was 1.15mm2 Data were 
analyzed by Student's t-test. 
Results 
Data are based on the experiments performed on total of 210 DRG cultures. 
Of these cultures 90 were used as control and in each experimental group there 
were at least 6 DRG cultures. 
Dorsal root ganglion explants from 2 day old rats established an extensive 
growth of neuronal and non-neuronal elements when cultured for 1 week. 
Explants had a tendency to flatten and spread but migration of DRG neurons 
into the growing zone surrounding DRG explant was not recorded (Figs 1 A,B 
and 4 A,B)- Normal SP- or CGRP-IR in 8 day old cultures is illustrated in Figs. 1 
and 4 A,B/C. The number of SP-IR DRG neurons was significantly larger than 
number of DRG neurons immunostained for CGRP (P<0.001, Student's t test). 
The growth of immunoreactive neurites was radial (Fig. 1A and 4A) and well 
Figure 1. Substance P -IR fibers and neurons in cultured DRG. A. Low 
power bright field micrograph of a 6 day old DRG organotypic culture 
started from a 2 day old rat and immunoreacted to SP. Numerous SP-IR 
cell bodies are present in the DRG explant and radially oriented fibers are 
surrounding the explant. No positive cell bodies are noticable outside the 
explant. B and C. Higher power micrographs of the same culture with 
easily visible cell bodies and fibers within and outside the DRG explant. D 
. A higher power bright field micrograph of a region outside the explant 
with numerous positive neurites. E. Phase contrast micrograph of the 
field shown in D with presentation of relation between positive fibers and 
nonneuronal elements. F. High power phase contrast micrograph of SP-
IR fibers (arrow heads) around normeuronal elements. Bars A,500|im, 
B,D and E, 160|im; C and F, SO^im. 
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supported by non-neronal elements in undergrowth (see Fig 1E,F). Both SP-IR 
and CGRP-IR fibers showed extensive branching and immunopositive boutons 
were abundant (Figs 1 D,F and 4 C). 
Effects of capsaicin on SP-IR sensory neurons 
In concentration of l|xM, capsaicin produced a decrease in the number of SP-
IR neurites. The effect was noticeable but was such that it had to be quantified 
with image analysis system (Table 1) and is not illustrated. Exposure of the 
cultures to 10|iM capsaicin resulted in a severe decrease of SP-IR from neurites 
surrounding DRG explant (Fig.2). By using predetermined 4 fields/evenly 
spaced aroimd the ganglia, we were not able to find any SP-IR fibers with image 
analysis system (Table 1). No obvious depressant effect of capsaicin was 
observed on the growth of non-neuronal elements in the growing zone 
surrounding the DRG explant (Fig. 2E). No SP-IR fibers were found in cultures 
exposed to 100|aM capsaicin. The effect of capsaicin on SP-IR cell bodies in the 
DRG explant proper was manifested as a decrease in the number of positive cell 
bodies and decrease or elimination of positive fibers (Fig. 2A,B). In 
concentration of 10 |iM capsaicin produced a 35% decrease of SP-IR neurons in 
cultures (Table 2). 
The effect of RTX on SP-IR fibers was dose dependent and quite similar to 
the effect of capsaicin. While the effect of lOnM RTX on SP-IR neurites was 
significant (Table 1), lOOnM RTX almost completely eliminated SP-IR fibers (Fig. 
3F and G). Similar to capsaicin, RTX in 10 and lOOnM concentrations decreased 
the number of SP-IR neurons in DRG explants. 100 nM RTX for a period of 6 
Table 1. The effect of capsaicin and RTX on the density of SP-IR and CGRP-IR neuiites in DRG organotypic 
cultures. Images of SP or CGRP inununoreactive neurites were captured with a vide camera and measured 
in 4 fields (l.lSmm^ each) evenly spaced around the ganglia (there were 6 ganglia in each group). The 
immunoreactive images underwent normalization (histogram stretching) and contour enhancement prior 
to interactive discrimination. The presented numbers are average areas in mm^ (+SEM) of IR fibers present 
in the field after backgrotmd values were subtracted. 
control c a p s a i c i n  ( u M )  RTX ( n m  
1 loygorrin Ifl. 10 10(V90min 100 
SP 0.039±0.007 0.025±0.005* 0.038±0.006 0 0.0149±0.005* 0.0434±0.009 0 
CGRP 0.26310.018 0.18Gi0.025' 0.1121:0.014* 0.159±0.022' 0.0322t0.007* 
* significantly different from control at P<0.001 
" significantly different from control at P<0.01 
Figure 2. Morphological chai\ges produced by capsaicin. 48 hours exposure 
to 10|xM capsaicin decreased the number of SP-IR cell bodies (A and B) and 
drastically decreased number of SP-IR fibers in the growing zone of the 
culture. C. SP-IR soma of sensory neurons in a culture exposed to lOOfiM 
capsaicin for 6 days. D and E. Photomicrographs of the field shown in in 
bright field (in D) and phase contrast (in E) illustrating the almost 
complete elimination of SP-IR fibers in a culture exposed to 10|iM 
capsaicin for 6 days and absence of a similar effect on nonneuronal 
elements. F. A high power micrograph of a short segment of SP-IR fiber 
marked with arrowheads in D and E. Bars; A 160nm, B,C/D and E lOOum: 
F SO^im. 
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Table 2. The effect of capsaicin and RTX on the ntunber of SP-IR and CGRP-IR 
cell bodies in DRG organotypic cultures 
control 10 caps lOOnM RTX 
n mean±SEM n meantSEM n meartbSEM 
SP-IR neurons 21 138±6 20 89±7* 20 64±7* 
CGRP-IR neurons 23 97±6** 21 47±4* 20 53±5* 
* sigiuficantly different from control at P<0.001 
** significantly lower than the number of SP-IR neurons at P<0.001 
Figure 3. The effects of RTX on SP-IR cultured sensory neurons. A. Low 
power micrograph of a culture exposed to lOOnM RTX for 48 hours. B. A 
higher power magnification of the same culture with SP-IR cell bodies 
inside the explant and several SP-IR fibers. C. lOOnM RTX for 6 days 
eliminated all SP-IR fibers in the growing area surrounding the DRG 
explant while many SP-IR cells are visible. D and F. Bright field and 
phase contrast high power micrographs of SP-IR fibers and nonneuronal 
immunonegative elements in a culture exposed to lOOnM RTX for two 
days. lOOnM RTX almost completely eliminated all SP-IR fibers (F, arrow 
heads are pointing towards structures that may be SP-IR segments of 
neurites) without an similarly severe effect on nonneuronal elements in 
the same field (G). Bars, A and C, 160|xm; B,D,E,F and G, lOOjim. 
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days produced about a 50% decrease in SP-IR cell bodies in DRG explants (Table 
2)-
In order to establish the time dependence of capsaicin and RTX effect, we 
exposed tissue to the compounds in different schedules and recorded the effect. 
In cultures that were exposed to IGOfiM capsaicin for 2 days a complete 
elimination of SP-IR fibers and significant decrease in the number of SP-IR cell 
bodies in DRG explant were observed (Table 2). 10^M capsaicin for 48 hours 
produced a drastic decrease in the number of SP-IR fibers and 6 day exposures 
resulted in almost a complete elimination of SP-IR fibers (Fig,2 D,E and F). l|xM 
capsaicin for 7 days capsaicin produced a significant decrease of SP-IR neurites. 
However, 10|iM capsaicin (n=18) or lOOnM RTX (n=28) failed to produce an 
effect, determined by examining immunoreactivity to peptides 6 days after 
exposure, when presented to cultures for 45 to 90 min (Table 1). Exposure of the 
cultures to RTX or capsaicin vehicle, in a concentration equal to one used with 
the irritants, was without any obvious effect. 
Effect of capsaicin and RTX on CGRP-IR neurons 
Exposure of the cultures to 10 and 100 capsaicin resulted in an obvious 
concentration-dependent decrease of CGRP-IR neurites surrounding DRG 
explant (Table 1, Fig. 4 QD,E). lOfxM capsaicin produced a noticeable decrease in 
the number of CGRP-IR fibers surrounding explants and 100|iM capsaicin 
produced an obvious deaease in the number of CGRP-IR neurites (Table 1, Fig. 4 
E,F). It should be noticed, however, that there were many more CGRP-IR fibers 
than SP-IR fibers exposed to corresponding concentrations of capsaicin. The 
effect of RTX on CGRP-IR fibers was quite similar to the effect of capsaicin. 
Figure 4. A. A low power bright field micrograph of a 7 day old organotypic culture started from a two day 
old rat and immunostained for CGRP. The culture is characterized by numerous CGRP-IR cell bodies in the 
DRG explant and CGRP-IR fibers radially oriented in the growing zone of the culture. B. A higher power 
nucrograph of CGRP-IR cell bodies and fibers within the DRG explant. C. A bright field micrograph of 
CGRP-IR neurites in a 7 day old culture. D. In concentration of 10|iM for 6 days capsaicin decreased ntunber 
of CGRP-IR DRG neurons and fibers. E and F. 100|iM capsaicin for 6 days produced an obvious decrease 
in the number of CGRP-IR fibers. G, H and I. I concentration of lOOnM for 6 days RTX produced an obvious 
decrease in the niunber of CGRP-IR cell bodies and neurites in DRG culture. Bars A and G, 500|im; B,D,E and 
H, 160|im, C,F and I, lOOjim. 
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lOnM RTX produced a significant decrease in the CGRP immunoreactivity in 
neurites (Table 1), but lOOnM RTX produced a decrease in the number of CGRP-
IR fibers of such magnitude that it could be obvious in a photography (Fig. 4G,H 
and I). It is important to notice that in no instance there was complete 
elimination of CGRP-IR fibers. The effect of capsaicin and RTX on the number of 
CGRP-IR cell bodies in DRG explant proper was similar to that on SP-IR cell 
bodies. After counting we established that there was significantly less CGRP-IR 
cell bodies in cultures exposed to lOOfiM capsaicin and lOriM RTX in comparison 
to controls (Table 2). 
The time-dependency of capsaicin and RTX toxic action was examined on 
CGRP-IR neurons and is similar to the effect of these toxins on SP-IR neurons 
and fibers. The capsaicin and RTX effect on CGRP-IR structures was dependent 
on time of exposure as well as on concentration of neurotoxins. In exposures of 
the cultures to 10|iM capsaicin or lOOnM RTX for 90 min no obvious effects on 
the CGRP-IR in neurites or cell bodies were recorded several days later when the 
culture was fixed and ICC procedure performed. The effects on CGRP was not 
quantified by using machine because there was no noticeable difference and the 
effect on more sensitive SP-IR neurites was absent (Table 1). 
On the basis of the data that unique sensory neuron-specific actions of 
capsaicin result in an influx of a number of cations including sodium, potassium 
and calcium which is specifically antagonized with ruthenium red (RR), we 
tested the effect of RR on 22 cultures. In 30 to 60 min exposures to 0.5 |XM RI^ 
we were unable to demonstrate convincing antagonistic effect on capsaicin or 
RTX (n=8). However, culture exposed to 0.5|iM RR for 6 hours or longer (n=8) 
failed to show any immunoreactivity to SP or CGRP 4 to 5 days after exposure. 
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In these cultures we were not able to see any immunoreactivity to two peptides 
in cell bodies or neurites. In higher concentration (l^M) RR resulted in 
disintegration of the cultures (n=6). This "depleting" effect of RR prevented its 
use in studying the mechanism of action of capsaicin and RTX. 
Discussion 
The present series of experiments has examined the effects of capsaicin and 
RTX on cultured peptidergic rat sensory neurons. Using immunocytochemistry 
for labeling SP- and CGRP-IR we have been able to study the long lasting effect 
of these two irritants on growth and survival of peptidergic neurons in 
organot)^ic cultures. 
It is clear that capsaicin and RTX, in a concentration dependent manner, 
eliminate SP -IR fibers and reduce, but do not eliminate, CGRP-IR fibers when 
presented to DRG cultures for period of 48 hours or longer. Exposure of the 
cultures to the irritants for 90 min did not produce a noticeable effect. It is also 
clear that neither capsaicin nor RTX eliminated all of the soma of SP-IR sensory 
neurons. These findings are in agreement with previous studies suggesting that 
processes of sensory neurons are much more sensitive to capsaicin than cell body 
[4,24]. In addition, our findings that SP-IR fibers were much more sensitive to 
capsaicin are in agreement with results demonstrating that SP is present in small 
DRG neurons and small C-fibers only while CGRP is localized in both small and 
large sensory neurons [15,28]. While it seems clear that only small fibers are 
affected by capsaicin and RTX in culture, the question of the toxicity of capsaicin 
and RTX towards all sensory neurons remains unanswered. Our findings that 
SP-IR cell bodies were present in cultures exposed to 100|iM capsaicin or lOOnM 
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RTX for 6 days convincingly demonstrates that these neurons are not killed by 
these irritants. Concentration-dependent effect towards peptidergic fibers and 
the greater effect on SP-IR fibers is further support that our procedure is sensitive 
enough and that these findings are not the result of some nonspecific factors. 
These results provide additional support for the data demonstrating that 
capsaicin and RTX act with great cellular specificity. Experimental approach, 
however, does not allow us to convincingly demonstrate that loss of peptide 
immunoreactivity is due to cell death. 
It is important to establish that the effect of capsaicin and RTX on cultured 
neurons is of long duration and is therefore different from depletion of peptides 
from neurites. In cultures exposed to these irritants for two days after which the 
cultures were returned to growing media for 4 or 5 days, we were not able to 
notice an increase in SP-IR fibers. These cultures were the same as cultures that 
were exposed to the irritants for 2 days just prior to fixation and ICC. In 
addition, it is important to establish that the sensitivity of fibers is concentration 
dependent. In cultures exposed to 10|iM capsaicin or lOnM RTX we were not 
able to produce complete elimination of SP-IR fibers, even though the cultures 
were exposed to neurotoxins for 7 days. However, 100|iM capsaicin and lOOnM 
RTX produced complete elimination of SP-IR fibers in two days. Single exposure 
to high concentrations of capsaicin produced a depletion of neuropeptides and 
excitatory amino acids from sensory neurons which may account for long lasting 
impairment of sensory functions (7,14). A strict correlation was found between 
the time-related recovery of neuropeptide levels in sensory terminals and 
functional recovery of sensory fibers (9). Present findings demonstrate important 
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role played by the tune of exposure. While singe exposure to capsaicin produced 
a reversible impairment of sensory function prolonged exposure in our 
experiments resulted in irreversible changes. This may be very important 
element in proposed use of capsaicin in chronic pain treatment. Due to strong 
effect of ruthenium red on the peptidergic neurons we were not able to study the 
mechanism of prolonged capsaicin effect on sensory neurons. However, the 
capsaidn-induced excessive Ca accumulation in primary afferents accounts for 
"sensory neuron blocking" action produced by high capsaicin and might account 
for "irreversible" depletion of SP and CGRP from capsaicin sensitive neurites [30, 
36]. Our inability to maintain the cultures for longer than 6 days following 
exposure to capsaicin makes it hard to be certain that effects are irreversible. 
Previous studies have provided evidence that sensitivity to capsaicin and 
content of SP are properties of nociceptive primary sensory neurons but it is not 
known whether these markers are expressed in all nociceptive sensory neurons. 
It has been documented that in dissociated cultures the fraction of cells sensitive 
to capsaicin and fraction of cells that contain SP-IR are larger than in freshly 
dissected DRG [1]. In our experiments, the fraction of the cells in the culture that 
is stained with antiserum to SP is larger than the fraction of that stained with 
CGRP. This result suggests that SP sensory cells survive preferentially in our 
culture conditions. Together with finding that capsaicin and RTX eliminate all 
SP-IR neurites and only a certain proportion of CGRP-IR neurites, these results 
suggest that relatively early in development a large fraction of cultured sensory 
neurons are able to express the functional properties of differentiated nociceptive 
sensory neurons, and are likely to be useful tool in studying the neuronal 
mechanisms of nociception. 
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CHAPTER 2. NEUROLIGAND-EVOKED CALCIUM-DEPENDENT 
RELEASE OF EXCITATORY AMINO ACIDS FROM SCHWANN CELLS 
A paper submitted to The Journal of Neuroscience 
Vladimir Parpura*, Fang Liu*, Ksenija Jeftinija' 
Srdija Jeftinija and Philip G. Haydon 
Abstract 
Bradykinin caused a receptor-mediated increase in release of the excitatory 
amino acids (EAAs) glutamate and aspartate from Schwann cell cultures 
obtained from dorsal root ganglia (DRG) together with an increase in the 
cytoplasmic level of free calcium. Perturbations which inhibited bradykinin-
induced calcium mobilization prevented the release of EAAs from glia. The 
addition of ionomycin caused a calcium-dependent release of EAAs. Therefore, 
bradykinin causes calcium dependent-release of EAAs from DRG Schwann cells. 
Bradykinin did not cause cell swelling and p-chloromercuriphenylsulphonic 
acid, an inhibitor of the electrogenic glutamate transporter, did not reduce 
bradyknin-induced EAA release. Therefore, bradykinin stimulates EAA release 
from Schwann cells through a mechanism that is neither the previously described 
volume regulated release mechanism nor due to the reversal of the glutamate 
transporter. 
* Contributed equally 
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Introduction 
It has been well established that glia have multiple roles in the nervous 
system which include the regulation of external potassium and the uptake of the 
excitatory amino adds glutamate and aspartate which are released from neurons 
into the extracellular space (NichoUs and Atwell, 1990; Barres, 1991; Kanai et al., 
1993). Several lines of evidence suggest that glial cells may also play important 
roles in releasing neurotransmitters. Schwann cells can release acetylcholine 
following axotomy of motoneurons (Dennis and Miledi, 1974). Retinal Miiller 
cell depolarization stimulates the release of glutamate through a reversal of an 
electrogenic glutamate uptake carrier (Szwatkovski et al., 1990). Depolarization 
causes the calcium-dependent release of the amino acid taurine from 
hippocampal glia (Philibert et al., 1988). Hyposmotic shock of cortical astrocytes 
stimulates cell swelling, an increase in internal calcium and a correlated release 
of the amino acids aspartate and taurine (Kimelberg et al., 1990; O'Connor and 
Kimelberg, 1993). Since glial cell calcium levels are regulated by 
neurotransmitters (Reisner et al., 1989; Cornell-Bell et al., 1990; Glaum et al., 1990; 
Charles et al., 1991; Cornell-Bell and Finkbeiner, 1991; Inagaki et al., 1991; Jensen 
and Chiu, 1991; McCarthy and Salm, 1991) this has prompted us to ask whether 
the neuroligand bradykinin causes a calcium-dependent release of excitatory 
amino acids (EAAs) from glial cells. 
In the peripheral nervous system, the nonapeptide bradykinin is released 
from its precursors, the kininogens, by the action of the enzyme kallikrein in 
response to trauma (Dray and Perkins, 1993). Bradykinin is known to mobilize 
calcium from inositol 1,4,5-trisphosphate (IP3)-sensitive calcium stores in several 
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cell types (for ref see Miller, 1987; Higashida and Ogura, 1991). Since bradykinin 
can mobilize internal calcium, we have asked whether this agent can cause the 
release of excitatory amino acids from glial cells derived from the dorsal root 
ganglia. This study demonstrates that the neuroligand, bradykinin, mobilizes 
internal calcium from Schwann cells which stimulates a calcium-dependent 
release of the excitatory anuno acids, glutamate and aspartate. 
Methods 
Cell Culture 
Glial cultures from DRG were obtained by modification of the organotypic 
procedure (Gahwiler, 1984). Following anesthesia with ether and decapitation, 
DRG from 1- to 2-day-old Sprague-Dawely rats were rapidly removed and 
washed in cold (4°C) oxygenated Gey's balanced salt solution (GBSS; Gibco) 
modified by the addition of 2% glucose. The capsular sheet was carefully" 
removed form the DRG to mirumize fibroblast contamination. DRG were than 
embedded onto a glass coverslip inlayed in a 35 mm dish (for release studies) or 
into a glass bottomed dish (for calcium imaging) in a plasma-thrombin clot. 
Cultures were maintained at 36°C in a humidified 5% C02/air atmosphere. The 
culture medium consisted of 25% horse serum (Gibco), 25% Earle's Balanced Salt 
Solution (Gibco) and 50% Basal Medium Eagle (Gibco) containing 36 mM 
glucose. The central part of explants which contains neuronal cell bodies was 
removed from established cultures (4 to 7 days in culture). The residual glial cells 
were maintained for additional 72 hours when all experiments were performed. 
Neurites degenerated 24 to 48 hours following the removal of the central portion 
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of explants leaving cultures containing only non-neuronal cells. The absence of 
neuronal elenients was confirmed by immunocytochemistry. 
In some experiments we enriched the number of Schwann cells in cultures 
using two methods (see Kleitman et al, 1992). In the Wood method, DRG were 
cultured for 48-96 hours in the presence of cytosine arabinoside (Ara-C; 5 
mg/mL). They were then transplanted to a new coverslip coated with chicken 
plasma. DRG explants were then cultured as described above to obtain DRG 
glia. In the Brockes method, DRG glia were incubated with Thy 1.1 antibody 
(hybridoma supernatant, American Type Culture, No. TIB103) and addition of 
rabbit complement (Sigma). Since Thy 1.1 is expressed on fibroblasts, but not on 
Schwann cells, this procedure leads to a complement mediated lysis of 
fibroblasts. In both culture methods, immunocytochemistry revealed that 
Schwann cells were enriched to >95%. 
Immunocytochemistry 
Antibody visualization was accomplished by using a Vectastain ABC kit 
(Vector) and the nickel-enchanced DAB method (Hsu et al., 1981). 
Immunocytochemistry was performed using antibodies directed against the 
synaptic proteins synaptophysin (1:1000; clone 7.4a, provided by R. Jahn) and 
synaptotagmin (1:5000; clone 41.1, provided by R. Jahn), against glial fibrillary 
acidic protein (GFAP; 1:5000, ICN Immimobiologicals) and against the low-
affinity NGF receptor (1:2000; 192-IgG, provided by E.M. Johnson, Jr.). Anti-
synaptophysin, synaptotagmin and anti-GFAP were found to be negative on 
DRG glia. Positive controls were performed with these antibodies using 
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hippocampal neurons and glia and using DRG explants in which axons were 
maintained in culture. 
EAA release 
The coverslips with glial cultures were mounted into a 50 |il perfusion 
chamber. A modified Ringer's perfusion solution containing (in mM) NaCl 128, 
KCl 1.9, KH2PO41.2, CaCl2 2.4, MgS041.3, NaHCOs 26 and glucose 10 
(pH=7.4) bubbled with 95% O2/ 5% CO2 was used for constant flow through at a 
rate of 200 ml/min and 35-37°C. After an equilibration period of 40 to 60 
minutes, samples of perfusate for amino acid determination were collected every 
minute. The amino acid content in samples was determined by high-
performance liquid chromatography (HPLC) with fluorescence detection 
(Lindroth and Mopper, 1979). Prior to injection, aliquots of samples were 
derivatized with o-phthalic aldehyde (OPA) 2-mercaptoethanol reagent (Pierce). 
Chromatography was performed on a 15 cm Microsorb-MV HPLC column 
(Rairun Instrument Co.) using a sodium acetate methanol gradient (pH=5.9). 
Bradykinin (10 nM; Sigma) and its antagonist (D-ArgO, Hyp3, fi-Thi^/^, D-Phe^)-
bradykirun (5 nM; Bachem Bioscience Inc.) were added to a perfusion solution. 
In control experiments we co-administered hydroxyproline (180 nM) together 
with bradykinin and determined that there is a 1 minute lag time from initiation 
of the addition of an agent until it is collected for HPLC analysis due to dead-
volume in the chamber. All figures for HPLC have been correspondingly 
corrected. Elevated K+ (50 mM) solution for HPLC was prepared by 
modification of a Ringer's solution where NaCl was replaced by KCl. 
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Calcium imaging 
Cells were loaded with fura-2 AM (4 ^M; Molecular Probes) for 40-60 
minutes at 37°C. of 25%(w/w) of Pluronic F-127 (Molecular Probes) was 
mixed with 1ml of 4nM Fura-2 AM ester solution. After washing, cells were kept 
for 30-60 minutes at 37°C to permit dye de-esterification . All experiments took 
place at 22-24°C. All image processing and analysis were performed using 
ratiometric software (QFM, Quantex Corp. or Image-l/Fl, v 1.63g, Universal 
Imaging Corp.). Background subtracted, ratio images (340/380 nm or 350/380 
nm) were used to calculate the [Ca^+Jj according to Equation 5 of Grynkiewicz et 
al. (1985). Calibration was performed in situ (Thomas and Delaville, 1991) using 
the Ca2+-ionophore 4-bromo-A23187 (10 |iM, Molecular Probes), An estimate of 
autofluorescence at each wavelength was achieved by addition of MnCl2 (20 
mM). Cells were included in analysis if the first addition of bradykinin caused a 
[Ca2+]i accumulation that was greater than 50% of the resting calcium level. 
During calcium imaging, bradykinin (10 nM) and elevated K+ (50 mM) were 
applied to glia for 1 minute by pressure ejection from a puffer pipette (opening 
diameter ~2-3 [im, 10 psi). All other drugs were uniformly applied to the bath by 
flow through. Repeated applications of bradykinin were spaced at 10 minute 
intervals. In some experiments the second bradykinin application followed the 
first application after 30 minutes. Ryanodine (10 |iM), caffeine (10 mM) and 
furosemide (5 n\M) were applied 10 minutes prior to the second application of 
bradykinin while thapsigargin was applied to the bath 30 minutes prior to the 
second application of bradykinin. Thapsigargin (1 |iM) was dissolved in dry 
DMSO. Control experiments with 0.1% (v/v) DMSO showed that DMSO did not 
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affect the action of bradykinin. Normal saline contained (in mM): NaCl 140, KCl 
5, MgCl2 2, CaCl2 2 and HEPES10 (pH 7.4). Calcium-depleted solution 
contained (in mM): NaCl 128, KCl 1.9, KH2PO41.2, CaCl2 0.2, EGTA 1, MgS04 
2.5, NaHC03 26 and glucose 10 (pH=7.4). Elevated K+ saline was prepared by 
modification of normal saline where NaCl was replaced by KCl. 
Max Chelator (version 5.6), written by Chris Patton at Stanford University, 
was used to calculate free extracellular calcium levels. The calculation includes a 
correction for extracellular Mg2+ions. 
Cell volume measurement 
To determine whether bradykinin caused a shrinkage of cells in our studies 
we monitored cell volume using BCECF as described by Eriksson et al. (1992). 
Cells were loaded by incubation in membrane permeable BCECF AM (10 |iM) for 
40-60 minutes, followed by 40 minutes for de-esterification. BCECF was excited 
at the pH-insensitive wavelength of 440 run. The emission intensity (510 DF 
40nm bandpass) was monitored with a SIT camera. When cells swell, BCECF is 
diluted, reducing the fluorescent intensity detected. We confirmed that this 
approach effectively detected volume changes in our studies by applying 
hyposmotic saline that was made by removing 50 mM of NaCl from our 
standard saline (see above). 
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Results 
Bradykinin stimulates excitatory amino add release from dorsal root ganglia 
Schwann cells 
Primary glial cultures of dorsal root ganglia (DRG) were obtained using a 
modification of the organotypic procedure (Gahwiler, 1984). Dorsal root ganglia 
were cultured on coverslips to permit neurite extension and migration of glial 
cells. After cultures were established, the central portion of the ganglionic 
explant, which contains neuronal cell bodies, was removed from the culture. 
During the next 48 hours the residual neurites degenerated leaving a neuron-free 
glial cell culture. The release of EAAs from these cultures was assayed using 
HPLC on the superfusate. The basal release of glutamate and aspartate into 
superfusate produced levels of 26 + 2 nM (mean + SEM; n= 13) and 6 + 1 nM, 
respectively. Addition of bradykinin caused a dose-dependent increase in 
release of the EAAs glutamate and aspartate from glial cultures. The threshold 
concentration of bradykinin was 1 nM. 10 nM bradykinin caused a greater than 
nine-fold inaease in the release of glutamate to 239 ± 42 nM and a greater than 
three-fold increase in aspartate to 21 + 3 nM (n=12; Fig. 1 A, B). A second 
application of bradykinin (n=12) similarly caused EAA release, although the 
magnitude of this response was attenuated (Fig. 1 A, B). This action is receptor-
mediated since the B2 receptor antagonist, (D-ArgO, Hyp3, fi-Thi^rS, D-Phe7> 
bradykinin (5 ^M), reversibly blocked the stimulatory action of bradykinin (n=6; 
Fig. IC). While bradykinin stimulated the release of glutamate and aspartate 
from glial cultures it did not significantly affect the release of serine. The basal 
level of serine was 14 + 2 nM compared to 16 + 2 nM in the presence of 
Figure 1. Bradykinin causes a receptor-mediated release of the EAAs, glutamate 
and aspartate, from DRG glia. Using HPLC, the amounts of glutamate and 
aspartate were determined in superfusate from rat DRG glia cultures. Addition 
of bradykinin (BK; 10 nM) caused a 9-fold elevation of glutamate release (A) and 
a 3-fold elevation of aspartate release (B). The B2 receptor antagonist, (D-ArgO, 
Hyp3, fi-Thi5/8^ D-Phe7)-bradykinin, blocked the secretory action of bradykinin 
(C). After washout of the antagonist, bradykinin reliably increased glutamate 
release. Points represent means + SEM. 
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bradykinin (n=13; p>0.5). These data demonstrate that the nonapeptide 
bradykinin potently causes the selective release of the EAAs glutamate and 
aspartate from DRG glia. 
The cell types present in the glial cultures derived from DRG was examined 
using inunimocytochemistry. We confirmed that glial cultures were neuron-free 
by using antibodies against the synaptic proteins synaptophysin and 
synaptotagmin. In these cultures immunoreactivity for these two synaptic 
proteins was absent while neurons were immunopositive in separate cultures. 
An antibody against glial fibrillary acidic protein was negative in DRG glial 
cultures. However, using an antibody against the low-affinity NGF receptor, 
characteristically expressed in Schwann cells localized distal to the site of 
axotomy, but not in surrounding fibroblasts (Taniuchi et al., 1988), we found that 
about 74% of the cultured glial cells possess NGF receptors (Fig. 2). Therefore 
the predominant glial cell type in these DRG cultures is Schwann cells. 
Since fibroblasts are likely to be a contaminating cell type in these cultures, 
we modified our techniques to enrich specifically in Schwann cells. Purified 
populations of Schwann cells (>95% of cells) were obtained by the Wood (n=6) 
and Brockes (n=6) methods (see Kleitman et al., 1992). These cultures showed 
sinular increases of the EAAs glutamate and aspartate in the superfusate after 
application of bradykinin. Bradykinin increased the glutamate levels in the 
superfusate from a basal level of 127+9 and 35+7 to 465+23 and 123+16 using the 
Brockes and Wood methods, respectively. We therefore conclude that the 
nonapeptide, bradykinin causes the release of the the amino acids glutamate and 
aspartate from DRG Schwann cells. 
Figure 2. DRG glia are immunopositive for the low-affinity NGF receptor. A) 
shows a phase-contrast micrograph of a field of DRG glia. 
Immunocytochemistry was performed on cultures using an antibody specific for 
the low-affiruty NGF-receptor which is expressed in Schwann cells after 
axotomy. B) shows a bright-field image of the same cells. Most of the glia are 
immunopositive indicating that they are Schwann cells. 
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Bradykinin mobilizes calcium in dorsal root ganglion Schwann cells. 
The release of neurotransmitter at neuronal synapses is calcium-dependent. 
To ask whether calcium might play a role in bradykinin-induced EAA release 
from DRG Schwann cells, we used ratiometric imaging techniques to monitor 
glial calcium levels. Cells were loaded with the membrane permeant calcium 
indicator fura-2 AM. Glia were imaged at low plating density, where they did 
not form a confluent monolayer. In resting conditions, the cytoplasmic calcium 
level of glia was 102 + 2 nM (n=136). Bradykinin (10 nM) reliably raised the 
cytoplasmic level of free calcium in 72% of cells tested (n=136 of 188). This 
increase of intracellular calcium reached the peak level of 747 + 24 nM (n=136; 
Fig. 3A) about 20 seconds after the onset of bradykinin application and was 
sustained for several minutes. In all subsequent experiments, we have reported 
the calcium levels for only those cells that responded to bradykinin. These 
bradykinin responsive cells had the morphology of Schwann cells. In some 
experiments we performed immunocytochemistry following calcium imaging 
using the antibody directed against the low-affinity NGF receptor which is 
present in Schwann cell cultures. Immuncytochemistry demonstrated that those 
cells that responded to bradykinin with an elevation of internal calcium were 
immimopositive with the antibody directed against the low-affinity NGF-
receptor (n=22 of 22 cells). Therefore, bradykinin elevates internal calcium levels 
in Schwann cells in a manner temporally coincident with the timing of release of 
glutamate and aspartate. 
Repeated applications of bradykinin reliably elevated calcium levels in 
Schwann cells (Fig. SB). The B2 receptor antagonist, (D-ArgO, Hyp3, C-Thi^/S^ D-
Phe7)-bradykinin (5 |iM), reversibly attenuated the stimulatory action of 
Figtue 3. Bradykinin mobilizes Ca2+ from internal stores in DRG glia. In (A) a 
focal application of bradykinin (BK; lOnM) elevates DRG glial calcium level to a 
peak 20 seconds after the onset of application. During sustained application of 
bradykinin, glial calcium is maintained at a stable elevated plateau from basal 
calcium level (dashed line). In (B) repeated applications of bradykinin (10 nM) 
caused repeated elevations of glial cytoplasmic calcium levels. In (C) the 
external calcium v^as reduced by exchange of normal saline for calcium-depleted 
saline. In this saline bradykinin was able to elevate calcium from its resting level 
indicating that calcium is mobilized from internal stores. However, a second and 
third addition of bradykinin had little effect on internal calcium levels (compare 
CwithB). Bars represent means + SEM. 
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bradykinin on calcium mobilization. In the presence of the B2 receptor 
antagonist^ the average resting calcium level (107 + 3 nM) was moderately 
increased by application of bradykinin (151 + 11 nM; n=32). However, after 
washout of the antagorust, bradykinin increased the cytoplasmic calcium level to 
480 + 24 nM (n=32), a value significantly greater than in the presence of the B2 
receptor antagoiust (Scheffe^'s test, p<0.001). 
Removal of external calcium from the bathing medium did not prevent the 
initial calcium mobilizing action of bradykinin (Fig. 3C). Cells were bathed in a 
caldum-depleted saline containing 0.2 mM calcium with the addition of 1 niM 
EGTA to yield an estimated free extracellular calcium level of 24 nM. We found 
that it was necessary to have some calcium in the bathing medium otherwise 
cells detached from the culture substrate. In this calcium-depleted saline, 
bradykinin elevated cytoplasmic free calcium from 98 + 2 nM to 713 + 38 nM 
(n=36). However, subsequent additions of bradykinin in calcium-depleted 
bathing medium had little calcium mobilizing action (n=36 and n=23 for the 
second and third applications, respectively; Fig. 3C). These data suggest that 
bradykinin mobilizes calcium from internal stores and that these stores must 
refill with calcium from the extracellular medium. 
Calcium mobilization from an internal store is further supported by 
observations using thapsigargin, an inhibitor of the Ca2+-ATPase of internal 
calcium stores. Following the first addition of bradykinin, thapsigargin (1 mM) 
was added to the culture to prevent reloading of internal stores with calcium. 
Addition of thapsigargin alone caused a transient increase in calcium from 90 + 5 
to 320 + 42 nM (n=15; Student t-test, p<0.0001). In the presence of thapsigargin, a 
second application of bradykinin failed to mobilize internal calcium as compared 
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to matched control cells which were incubated in the DMSO carrier saline (n=26, 
Scheffe^'s test, p<0.001; Fig. 4) supporting the notion that bradykinin mobilizes 
calcium from an internal store. To determine the type of internal calcium store 
which bradykinin acts on, we added ryanodine, which can block the release of 
calcium from the caffeine-sensitive calcium store. Ryanodine (10 |iM) did not 
affect the calcitmi mobilizing action of repeated applications of bradykirun (n=21 
and n=20 for the second and third applications, respectively; Scheffe^'s test, 
p>0.25; Fig. 4C). Furthermore, the sustained presence of caffeine (10 mM) did not 
affect the calciimi-mobilizing action of bradykinin (n=23, Scheffe^'s test, p>0.25; 
Fig. 4C). Thus, we conclude that bradykinin predominantly mobilizes calcium 
from a ryanodine/caffeine-insensitive internal calcium store. This suggests that 
bradykinin's actions are mediated through an IP3- sensitive calcium store. This is 
consistent with other studies which have shown that bradykinin causes 
phosphoinositide hydrolysis in oligodendrocytes and astrocytes (Ritchie et al., 
1987). 
Excitatory amino acid release from Schwann cells is calcium-dependent 
Calcium-imaging data raise the possibility that bradykinin stimulates EAA 
release through mobilizing internal calcium. To test whether calcium is 
necessary for glutamate release we determined whether multiple applications of 
bradykinin caused glutamate release in calcium-depleted saline. Consistent with 
the ability of bradykirun to mobilize calcium in calcium-depleted saline the first 
bradykinin application stimulated the release of glutamate from glial cultures 
(n=6. Fig. 5A) in calcium-depleted saline. However, a second application of 
bradykinin in calcium-depleted saline did not cause significant glutamate release 
Figure 4. Bradykinin mobilizes calcium from internal calciiun stores. A) Two 
applications of bradykinin (BK, 10 nM) reliably elevate internal Schwann cell 
calcium. Addition of DMSO (0.1 % v/v) did not attenuate the bradykinin 
induced calcivim response. B) Addition of thapsigragin (l|iM) in DMSO 
following the first addition of bradykinin, prevented subsequent applications of 
bradykinin from mobilizing internal calcium. C) Relative Ca2+ mobilization is 
expressed as percentage values of [Ca^+Jj accumulation (peak value subtracted 
from resting; DCa) during the 2nd and 3rd applications of bradykinin (ACan) 
compared to the 1st (ACai) (relative calcium mobilization =ACan/ACai x 100). 
The presence of ryanodine (10 nM; Molecular Probes) or caffeine (10 mM; Sigma) 
in the bathing solution did not prevent bradykinin from elevating [Ca2+]i. 
However, thapsigargin (1 nM; Sigma), but not its DMSO (0.1 % v/v) carrier, 
applied to the bath following the first addition of bradykinin, reduced the 
bradykinin-induced increase of [Ca2+]i during the second addition of 
bradykinin. Taken together, these data demonstrate that bradykinin mobilizes 
calcium from internal stores and reloading of these stores requires the presence 
of external calcium. Points (in A and B) and bars (in C) represent means ± SEM. 
To compare effects of different drugs on effect of bradykinin one-way ANOVA 
with post hoc Scheffe^'s comparison was used. Significance was established at 
p<0.001(»). 
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Figure 5. Calcium is necessary and sufficient for glutamate release from DRG 
glia. The first application of bradykinin (BK) caused glutamate release from glial 
cells bathed in calcium-depleted saline. However, a second application of 
bradykinin failed to produce significant release of glutamate (A). After 
incubation with BAPTA-AM (50 |iM; Molecular Probes) for 30 minutes, cells 
were unable to release glutamate in response to bradykinin showing that 
increase of intracellular calcium is necessary for glutamate release (B). 
Sufficiency of caldum to induce glutamate release has been established using 
ionomycin. Cells released glutamate after application of ionomycin when bathed 
in normal calcimn saline, but not when bathed in calcium-depleted saline (C). In 
both calcium-depleted and BAPTA treated cells, there was a slight augmentation 
of basal glutamate levels in the supernatant. Points represent means ± SEM. 
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(n=6; Student t-test, p>0.5; Fig. 5A). To further test the calcium hypothesis for 
glutamate release, we incubated glial cultures for 30 minutes in 50 |iM BAPTA-
AM in caldum-containing saline. This membrane permeant calcium chelator 
blocked the stimulatory action of bradykinin on glutamate lelease (n=6; Student 
t-test, p>0.3; Fig. 5B). 
As a critical test of the calcium hypothesis we exposed cultures to the 
caldum-ionophore, ionomycin, in calcium-containing saline. Addition of 
ionomydn (5 |iM) stimulated the release of both glutamate (n=6; Student t-test, 
p<0.025. Fig. 5C) and aspartate (data not shown). Ionomycin was without 
stimulatory effects when glia were bathed in calcium-depleted saline (n=6; 
Student t-test, p>0.9; Fig. 5C). Taken together, these data demonstrate that 
caldum is mobilized in Schwann cells coincident with the timing of EAA release. 
This caldum mobilization is both necessary and sufficient for stimulating the 
release of EAAs from Schwann cells. 
p-chloromercuriphenylsulphonic add does not inhibit EAA release from 
Schwann cells 
Glutamate can be released from cells during depolarization through the 
reversal of an electrogenic glutamate uptake carrier (Szwatkowski et al., 1990). 
To determine whether this mechanism might regulate glutamate release from 
DRG Schwann cells, we depolarized them using elevated potassium saline. 
Application of elevated K+ (50 mM) did not cause a change in Schwann cells 
calcium levels (n=27; Student t-test, p>0.1) nor stimulated EAA release from DRG 
glia. In control conditions we detected 48 + 7 nM glutamate in the superfusate. 
Following addition of 50 mM K+ saline we detected 46 + 6 nM glutamate (n=6. 
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Student t-test, p>0.7). The lack of glutamate release from DRG glia during the 
application of elevated K+ saline is not consistent with a role for the reversal of a 
glutamate uptake carrier in mediating the bradykinin-induced release of EAAs 
from DRG Schwann cells. Futhermore, addition of the glutamate transporter 
inhibitor p-chloromercuriphenylsulphonic acid (p-CMPS; 50 mM) did not reduce 
the bradykinin stimulation of glutamate and aspartate release. However 
consistent with previous observations using glutamate transporter inhibitors 
(Balcar and Johnston, 1971; Isaacson and Nicoll, 1993), p-CMPS did elevate the 
basal level of glutamate in the bathing medium. 
EAA release from Schwann cells is not mediated by a cell swelling-dependent 
mechanism. 
Hyposmotic media cause a swelling-dependent release of aspartate and 
taurine from cortical astrocytes (Kimelberg et al, 1990). This release is sensitive 
to anion transport inhibitors. We determined whether Schwann cells have a 
similar sensitivity by incubating them in furosemide (5 mM). Bradykinin-
induced release of glutamate was reduced by 98% (n = 5; p <0.0001, Student t-
test) in the presence of furosemide (Fig. 6A). To ask whether furosemide inhibits 
glutamate release by acting at the level of the calcium signal we determined the 
effect of furosemide on bradykirun-induced calcium mobilization. Using 
repeated applications of bradykinin (see Fig. 4 for protocol) we found that 
addition of furosemide (5mM) significantly attenuated (n = 43; p <0.0001, 
Student t-test) the ability of the second application of bradykinin to mobilize 
calcium (Fig. 63). 
Figtue 6. Furosemide, an anion transporter blocker, inhibits bradykinin-induced 
glutamate release from Schwann cells. In A) an application of bradykinin in 
presence of furosemide (5 mM, Sigma) did not cause glutamate release from 
Schwann cells. In parallel, bradykinin-induced calcium mobilization is greatly 
attenuated by the presence of furosemide in bathing medium (B). Relative Ca2+ 
mobilization is expressed as percentage values of [Ca2+]| accumulation (peak 
value subtracted from resting; DCa) during the 2nd application of bradykinin 
(ACa2) compared to the 1st (ACai) (relative calcium mobilization =ACa2/ACai x 
100). (C) BCECF-loaded Schwann cells were used to determine the effect of 
bradykinin on cell volume. BCECF emission intensity, in response to excitation 
at 440 run, was used to monitor cell volume. Addition of hyposmotic medium 
significantly reduced the fluorescence intensity. Subsequent addition of 
bradykinin at a concentration of 10 nM, which stimulates calcium elevations and 
EAA release, did not change the volume of Schwann cells. A second addition of 
hyposmotic medium demonstrated, however, that these cells were still able to 
respond with volume changes. Points (in A) and bars (in B and C) represent 
means + SEM. Student t-test was used to determine the significance of 
furosemide effect on bradykinin-induced calcium mobilization while in (C) a 
paired t-test was used. Significance was found to be p<0.0001 (*). 
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Since furosemide reduces bradykinin-induced calcium mobilization, it is not 
clear whether the release mechanism per se is sensitive to this anion transport 
irUiibitor as has been demonstrated in astrocytes in response to hyposmotic 
media (Kimelberg et al, 1990). Therefore, to further test whether bradykinin 
stimulates glutamate release from Schwann cells through a cell swelling 
mechaiusm we monitored cell volume during bradykinin application. Schwann 
cells were loaded with BCECF and the fluorescence emission was monitored in 
response to excitation at the pH-insensitive wavelength of 440 nm. Sequential 
additions of hyposmotic media repeatedly and reversibly reduced the intensity 
of BCECF fluorescence demonstrating that this method can detect swelling of 
Schwarm cells (Fig. 6C; n = 36, p < 0.0001; paired t-test). However, application of 
bradykinin (10 nM, 1 minute), a stimulus which mobilizes calcium and evokes 
EAA release, did not change Schwann cell volume (Fig. 6C; n = 36, p > 0.25; 
paired t-test). Since bradykinin does not regulate cell volume, it does not liberate 
EAAs from Schwarm cells through a previously described cell swelling-
dependent release mechanism. 
Discussion 
Our data demonstrate that the release from Schwann cells of the excitatory amino 
adds, glutamate and aspartate, is regulated by the neuroligand bradykinin. 
Bradykinin causes the mobilization of calcium from internal stores in Schwann 
cells within seconds of addition to cultures. This calcium elevation is sustained 
for several minutes. In parallel cultures, bradykinin releases glutamate and 
aspartate within one minute of delivery of bradykinin to the superfusion 
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chamber. Thus, the bradykinin-induced caldiuii elevation is temporally 
coincident with the release of EAAs raising the possibility that it is required for 
BAA release. To test this hypothesis we asked whether calcium elevations are 
both necessary and sufficient for EAA release. When we by-passed the 
bradykinin receptor and directly elevated internal calcium using calcium 
ionophore EAA release was stimulated as long as a source of calcium was 
present. The calcium-elevation stimulated by bradykinin was also shown to be 
necessary for the release of EAAs. When calcium mobilization was blocked 
using BAPTA-AM or by removing external calcium during repeated bradykii\in 
applications/ bradykirun no longer stimulated the release of EAAs from Schwann 
cells. Taken together these data demonstrate that bradykinin mobilizes internal 
calcium in Schwann cells which is both necessary and sufficient to stimulate the 
release of glutamate and aspartate. 
A key issue to address is the nature of the release mechanism that is 
responsible for EAA liberation from Schwann cells (Attwell, 1994; Smith 1994). 
This release mechanism may take at least three forms (Fig. 7). Glutamate can be 
released through the reversal of a glutamate transporter (Fig. 7A). Retinal Miiller 
cells, for example, release glutamate in a calcium-independent fashion in 
response to elevated [K+]o due to the reversal of the normal glutamate uptake 
mechanism (Szwatkovski et al., 1990). This mechanism probably does not 
account for the release of EAAs in response to bradykinin in DRG Schwann cells 
since the action of bradykinin is calcium-dependent, glutamate release is not 
stimulated by depolarizing stimuli which would reverse the glutamate uptake 
carrier and p-CMPS does not block bradykinin-induced release of EAAs. 
Figure 7. Summary of EAA release mechanisms. Previous studies have demonstrated that EAAs can be released 
from cells due to (A) the reversal of an electrogenic transporter during depolarization (Szatkowski et al., 1990). 
Alternatively hyposmotic medium causes cell swelling which stimulates EAA release that is sensitive to the anion 
transport inhibitor, furosemide (B) (Kimelberg et al., 1990). Since Schwann cell depolarization does not induce 
EAA release, the glutamate transport inhibitor p-CMPS does not inhibit bradykinin stimulated EAA release and 
since bradykinin does not induce swelling of Schwann cells, neither of these release mechanisms is likely to be 
responsible for neuroligand-induced EAA release. The properties of the bradykinin induced EAA release 
mechanism of Schwann cells are summarized in (C). Bradykinin acts on a B2 receptor which leads to a furosemide-
sensitive elevation of calcium. Calcium ions, liberated from internal stores, are both necessary and sufficient to 
stimulate EAA release from Schwann cells. Further studies are required to determine whether this caldum-
dependent release mechaiusm is similar to the neuronal vesicular release mechanism of synaptic trarismission. 
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In cortical astrocytes hyposmotic medium causes cell swelling and the 
consequent release of glutamate, taurine and aspartate (Kimelberg et al., 1990; 
O'Connor and Kimelberg, 1993; Fig. 7B). An anion transport blocker, 
furosenude, reduces cell swelling dependent release from cortical astrocytes 
(Kimelberg et al., 1990). This raises the hypothesis that bradykinin causes cell 
swelling which in turn stimulates EAA release from Schwann cells. We 
therefore tested the action of furosemide on EAA release. In Schwann cells 
furosemide reduced bradykinin-stimulated calcium mobilization and EAA 
release. Since furosemide significantly modified bradykinin-induced calcium 
signaling this experiment did not allow us to determine whether the cell swelling 
dependent release mechanism is utilized. Therefore, we directly measured cell 
volume and asked whether bradykinin induces cell swelling. Using BCECF our 
data clearly demonstrated that while hyposmotic media induced swelling of 
Schwann cells, bradykinin did not. These data are not consistent with 
bradykinin inducing the release of EAAs through the previously described 
volume regulated mechanism (Kimelberg et al., 1990; O'Connor and Kimelberg, 
1993). Furthermore, these previous studies have shown that cell swelling 
induced EAA release is calcium-independent, while calcium is both necessary 
and sufficient for bradykinin-induced EAA release from Schwann cells. 
A third potential mechanism of bradykinin-stimulated EAA release is 
through a membrane/vesicle release mechanism similar to that of neurons. 
Cultures were free of immunoreactivity for the synaptic proteins sjmaptophysin 
and synaptotagmin while axons of DRG explants (separate cultures; data not 
shown) were immunopositive for these synaptic proteins. Thus, proteins 
characteristic of neuronal transmitter release apparatus are absent in Schwann 
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cells. However, these observatioi\s do not rule out quantal membrane release 
mechanisms since muscle (Dan and Poo, 1992) and fibroblasts (Adler et al., 1993) 
have been demonstrated competent to release neurotransmitters in a quantal 
fashion. 
Figure 7C summarizes our current understanding of the bradykinin-induced 
EAA release mechanism. Bradykinin, acting through a receptor, mobilizes 
internal calcium which is necessary and sufficient to stimulate EAA release from 
Schwaim cells independent of cell volume changes. The nature of this calcium-
dependent release apparatus remains to be defined. 
The regulated release of neurotransmitters from glia may be a widespread 
property. Stimulation of motoneurons leads to the elevation of calcium in the 
Schwann cells which surround the presynaptic terminal 0ahromi et al., 1992). 
After denervation, Schwann cells have been shown capable of releasing 
acetylcholine (Dennis and Miledi, 1974). Depolarization of hippocampal 
astrocytes causes the calcium-dependent release of the amino acid taurine, but 
not glutamate (Philibert et al., 1988). Recently, we demonstrated that glial cells 
from the cerebral cortex release aspartate and glutamate in response to 
bradykinin (Parpura et al., 1994). Since many neurotransmitters utilized by the 
nervous system can mobilize calcium in glia (Reisner et al., 1989; Cornell-Bell et 
al., 1990; Glaum et al., 1990; Charles et al., 1991; Cornell-Bell and Finkbeiner, 
1991; Inagaki et al., 1991; Jensen and Chiu, 1991; McCarthy and Salm, 1991), it is 
possible that neurons have in addition to their fast neuron-neuron synaptic 
actions, a calcium mobilizing action on neighboring glia (Dani et al., 1992) which 
in turn leads to the release of other neurotransmitters from glia that may serve 
secondary roles in glia-neuronal transmission. In support of this possibility 
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recent studies have demonstrated that glia can signal to neurons (Parpura, 1993; 
Nedergaard, 1994; Parpura et al., 1994). 
The specific roles for release of excitatory amino acids from glial cells 
remains to be elucidated. In the peripheral nervous system, bradykinin is 
released from its precursors, the kirunogens, by the action of the enzyme 
kallikrein in response to trauma (Dray and Perkins, 1993). Thus, during trauma 
and tissue damage, bradykinin is produced where it can initiate the transmission 
of nociceptive information. Perhaps the bradykinin induced-release of glutamate 
and aspartate from Schwarm cells is involved in mediating certain aspects of 
immediate responses to injury. In the central nervous system, elevations of 
external glutamate and aspartate are likely to modulate neuronal properties 
including excitability and synaptic transmission. Given the important role of 
glutamate in the induction of long-term potentiation, it will be important to 
determine whether glia regulate synaptic plasticity, learning and memory by 
releasing the neurotransmitter glutamate and whether excessive glutamate 
release from glia also contributes to neurodegenerative disorders. 
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CHAPTER 3. ATP-EVOKED Ca2+-DEPENDENT RELEASE OF EXCITATORY 
AMINO ACIDS FROM CULTURED SCHWANN CELLS 
A paper to be submitted to Brain Research 
Fang Liu, Ksenija Jeftinija, Srdija Jeftinija 
Abstract 
The specific objective of this study was to determine the mechanism by which 
ATP evokes release of EAAs from cultured Schwann cells. Basal concentrations of 
aspartate and glutamate in Schwann cell cultures were 7.6410.74 nM (mean±SEM) 
and 30.52±3.89 nM, respectively. Perfusion application of 100|iM ATP for 2 
minutes to cultured Schwann glia resulted in an 201±28 % increase of aspartate 
and 203±15 % increase of glutamate. A second application of ATP 10 minutes after 
the first application similarly caused EAA release, although the magnitude of this 
response was attenuated. Application of ATP to glia for 10 minutes resulted in a 
peak inaease in the release followed by a decline to a plateau significantly higher 
than baseline release. Bath application of adenosine (100|xM) was without effect on 
release of EAAs suggesting involvement of P2 receptors. The release of EAAs 
evoked by ATP was not abolished in low Ca^+-EGTA saline. Pretreatment of the 
glial cultures with 50|aM BAPTA-AM abolished the effect of ATP. Thapsigargin 
(l|iM), an inhibitor of Ca2+-ATPase or the Ca2+ pump of internal stores, 
significantly reduced the release of EAAs evoked by ATP. Our results show that 
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ATP evokes the release of EAAs from cultured Schwann cells by activating 
intracellular calcium stores. 
Introduction 
Although the fimctional importance of intracellular adenosine 5'-
triphosphate (ATP) levels in cellular metabolism has been recognized for many 
years, the observation that extracellular ATP can influence neurotransmission, 
cardiac function, muscle contraction and other biological processes is more recent 
(reviewed by Gordon, 1986; Bumstock, 1990). ATP acting as a neurotransmitter 
or neuromodulator performs important functions in the central and peripheral 
nervous system. 
It has been shown that ATP can be released or co-released with acetylcholine 
or norepinephrine from nerve endings (Bumstock, 1976; 1986a; 1986b; Fyffe and 
Perl, 1984). Extracellular ATP excites a suppopulation of rat dorsal horn neurons 
(Jahr and Jessel, 1983) and rat sensory neurons (Krishtal et al., 1988). It was also 
reported ATP depolarized cultured hippocampal neurons and induced release of 
glutamate from the neurons (Inoue et al., 1992). 
The actions of ATP are mediated by P2-purinoceptors which are present on 
many cell types including neurons and astrocytes (Phillis and Wu, 1981; Salter 
and Henry, 1985; Gebicke-Haerter et al, 1988; Pearce et al., 1989). There is 
evidence that activation of P2-purinoceptors leads to an increase in intracellular 
calcium in a variety of excitable and unexcitable cells (O'Connor et al., 1991; El-
Moatassim et al., 1992). Two mechanisms are involved in ATP-evoked 
intracellular calcium increase. First, ATP can activate nonselective cation 
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channels, resulting in depolarization and subsequent opening of voltage-
dependent Ca2+ charmels (Nakazawa and Matsuki, 1987; Friel, 1988). The 
increased calcium influx is also the result of direct activation of ATP-gated cation 
channels (Benham and Tsien 1987; Charest et al., 1987). Second, the extracellular 
ATP can stimulate the breakdown of inositol phospholipids and the resulting 
increase in inositol 1,4,5,-triphosphate (IP3) is responsible in part for the elevation 
of cytosolic Ca2+ (Boeynaerus et aL, 1988; Danziger et al., 1988). 
There is an increasing body of evidence showing that neuroglia may be more 
actively involved in brain function than has been previously thought. It has been 
demonstrated that neuroglia have multiple roles in the nervous system which 
include the regulation of extracellular potassium, the uptake of excitatory amino 
adds (EAAs) and the release of neurotransmitter such as glutamate (Glu), 
aspartate (Asp) and acetylcholine (ACh) (Nicholls and Atwell, 1990; Barres, 1991; 
Kanai et al., 1993; Snuth, 1994). Our recent study shows that the release of the 
excitatory neurotransmitter glutamate from glial cells plays a key role in glia-
neuron signalling (Parpura et al., 1994a). 
Although it has been determined that extracellular ATP can stimulate Ca2+ 
influx and increase intracellular calcium in cultured astrocytes (Neary et al., 1991; 
Salter and Hicks, 1994), little is known about the effects of extracellular ATP on 
Schwann cells, which are the predominate glial cells in the peripheral nervous 
system. Our previous study shows that the neuroligand bradykinin can induce 
the release of EAAs from cultured Schwann cells in a Ca2+-dependent manner 
(Parpura et al.; 1994b). This evidence prompted us to propose that extracellular 
ATP might influence the functions of Schwann cells. In this study, we first 
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demonstrate that ATP can evoke release of EAAs from cultured Schwann and the 
intracellular Ca2+plays a role in the release of EAAs. 
Materials and Methods 
Cell culture Organotypic DRG cultures will be prepared according to modification 
of methods described by Gahwiler (1984), and previously reported (Jeftinija et al., 
1991). Following decapitation, DRG from one to four day old Sprague-Dawley rats 
will be rapidly removed and washed in cold (4oC) oxygenated Gey's balanced salt 
solution (GBSS, Gibco) modified by the addition of 2.0% glucose. Culturing will be 
carried out on glass coverslips which are specially prepared by soaking 24 hours in 
xylene, 4 hours in acetone, 24 hours in absolute alcohol, and dried for 30 min at 80° 
C. Isolated explants will be placed on a glass coverslip completely covered with 
chicken plasma (Sigma) and coagulated by adding thrombin solution (Sigma). The 
coverslips bearing the explants will be placed into 35 mm Petri dishes. Cultures will 
be incubated in a humid 5% COz atmosphere at 37° C. The culture medium 
contained 25% horse serimi, 25% Earls Balanced Salt Solution, 50% Basal Medium 
Eagles with added glucose (6.4 mg/ml). When the culture is incubated for 3-4 days, 
it has a lot of processes arising from DRG explant and also Schwann cells in 
growing zone. In order to get DRG glial cells, we'll remove the central part of 
explant which contains neuronal cell bodies from established cultures (4 to 5 days 
old culture). The residual glia cells left behind will be maintained for additional 72 
hours. Fibroblasts will be removed by incubating the culture with thy 1.1 antibody 
(hybridoma supernatant, American Type Culture, No. TIB103) and addition of rabbit 
serum complement (Sigma). This procedure is used to lysogenize the fibroblasts and 
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purified Schwann cells. The DRG glial cells and fibroblasts were identified by 
inununocytochemistry using antibodies against low affinity NGF receptor and 
fibronectin. Immunocytochemistry revealed that at least 95% of the cell population 
were Schwann cells. 
Release method and HPLC This procedure has been developed in our 
laboratory. The coverslips with cell cultures are mounted in a 50 ml perfusion 
chamber. The modified Ringer's perfusion solution (in mM: NaCl 127, KCl 1.9, 
KH2PO4I.2, CaCl2 2.4, MgS041.3, NaHCCb 26, glucose 10, pH7.4) bubbled vnth 
95% oxygen and 5% carbon dioxygen is pumped into the perfusing system by a 
n\inipuls pump at a rate of 200 ml/min. After an equilibration period of half an 
hour, samples of perfusate are collected every minute for amino acids 
determinations. The amino acid content in the samples is determined by high-
performance liquid chromatography (HPLC) with fluorescence detection using a 
Shimadzu system. Prior to injection, aliquots of the samples are derivatized with 
o-phthalaldehyde (OPA) 2-mercaptoethanol reagent (Pierce). Chromatography is 
performed on a 15 cm Rainin column using a pH 5.9 sodium acetate methanol 
gradient. 
The concentrations of Glu and Asp are expressed in nMols. Basal 
concentrations of EAAs were determined as the mean of the EAA content of 
three samples collected just prior to stimulation with ATP, adenosine or 
bradykirun. All data are presented as the mean values ± S.E.M.. The data were 
analyzed by Student's t-test. 
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Results 
ATP evokes EAA release from dorsal root ganglion Schwann cells 
The basal concentration of glutamate and aspartate was 30.52±3.89 nM 
(meardSEM) and 7.64±0.74 nM, respectively. Application of 100|iM ATP for two 
min produced a significant increase in the concentrations of Glu and Asp. The 
peak concentrations of Glu and Asp were 203±15 % (n=8, p<0.0005) and 201+28 
% (n=8, P<0.005) of the basal concentration, respectively. These data show that 
extracellular ATP can stimulate the release of EAAs from cultured Schwann cells. 
A second application of ATP similarly caused EAA release, although the 
magnitude of this response was attenuated. The second peak concentrations of 
glutamate and aspartate were 163± 11% (n=8, P<0.0005) and 176±11% (n=8, 
P<0.0005) of the control concentration, respectively (Figure la and Figure lb). 
Application of ATP to glial cultures for 10 minutes resulted in a biphasic 
response, which involved a increased glutamate peak that was 232±10 % (n=4, 
P<0.005) of the basal concentration followed by a declining release to a sustained 
release plateau significantly higher than the control release. The increased release 
returned to the basal concentration when ATP was removed (Figure Ic). This 
data illustrate that prolonged exposure of ATP to Schwann cells could induce 
long lasting release of EAAs. 
Pi^-purinoceptors are not involved in ATP-evoked release of EAAs 
To test receptor specificity of ATP-evoked release of EAAs, we used 
adenosine to stimulate cultures. Application of adenosine (100 |aM) for two 
minutes failed to induce release of EAAs from cultured Schwann cells 
Figure 1. Time covirse of changes in the concentration of glutamate and aspartate following exposure of the 
cultures to ATP or adenosine. 
(a) Application of 100|iM ATP for two minutes significantly increased concentration of glutamate. 
(b) Application of lOO^iM ATP for two minutes significantly inaeased concentration of aspartate. 
(c) The effects of exposure of 100 |iM ATP for different time periods. Application of ATP to the cultures for ten 
minute resulted in a biphasic response with a initial peak followed by a decline to a sustained plateau which is 
higher than that in control group which had a two minute application of ATP. 
(d) Adenosine (100 nM) failed to induce release of glutamate. This suggests that Pi-purinoceptors are not 
involved in this release. Furthermore, it implies that the ATP-evoked release of glutamate might be mediated by 
I P2-purinoceptors. 
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(n=4, P>0.3). Exposure of 10 nM bradykinin to the cultures ten minutes after the 
application of adenosine evoked a six fold increase of glutamate release. This 
result indicates that these cultures responded to the stimulation of bradykinin 
very well, although they were not sensitive to adenosine (Figure Id). 
It has been proposed that there are two classes of purinergic receptors 
(Burnstock/1978). One is the adenosine-sensitive Pi-purinoceptor, and the other 
one is the ATP-sensitive P2-purinoceptor. The latter is insensitive to adenosine. 
Because adenosine did not induce the release of EAAs from cultured Schwann 
cells, the possibility that the Pi-purinoceptor is involved in this process is 
eliminated. Furthermore, it implies that ATP might evoke release of EAAs by 
activating P2 -purinoceptors. 
ATP-induced release of EAAs is calcium-dependent 
ATP has been found to increase intracellular Ca2+ concentration in many 
cells (reviewed by Burnstock, 1990). On the basis of this evidence, we have 
investigated whether Ca2+ plays a role in ATP-induced release of EAAs. 
Cultures were incubated with low Ga2+ (0.2mM), high Mg2+ (2.5 mM), EGTA 
(1 mM) saline for 30 minutes. We found that, after removing the extracellular 
calcium, ATP still caused a increased release of EAAs similar to that seen in the 
control group. The peak concentration of glutamate was 162+25 % of the basal 
concentration (n=6, P<0.05). This result demonstrated that extracellular calcium 
is not involved in ATP-induced release of EAAs from Schwann cells (Figure 2a). 
In order to determine whether Ca2+ from internal stores is involved in 
glutamate release, we pretreated cultures with 50 piM BAPTA-AM [l,2bis(2-
aminophenoxy) ethane-N,N,N',N'-tetraceticacid, acetoxymethyl ester] saline for 
Figure 2. ATP-evoked release of glutamate is Ca2+-dependent. 
(a) Low Ca^+-EGTA saline didn't significantly affect the ATP-evoked release 
of glutamate. 
(b) BAPTA-AM (50 ^ iM), the membrane permeant calcium chelator, blocked 
the ATP-evoked glutamate release. 
(c) Thapsigargin (1 |iM), the inhibitor of the Ca2+-ATPase of internal calcium 
stores, abolished the stimulatory effect of ATP on release of glutamate. 
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30 minutes. The ATP-induced maximal release of glutamate was only 101±6 % 
(n=4, P>0.4) of the control concentration. BAPTA-AM, the membrane permeant 
calcium chelator, blocked the effect of ATP on glutamate release. This result 
suggests that intracellular Ca2+ might be responsible for ATP-induced release of 
glutamate (Figure 2b). 
To further test the involvement of intracellular Ca2+ in glutamate release, 
thapsigargin (1 |iM), an inhibitor of the Ca2+-ATPase of internal calcium stores 
(Thastrup, 1990), was applied to the cultures for 30 minutes before the 
application of 100 |i,M ATP. The maximal release of glutamate evoked by ATP 
was 104±7 % (n=4, P>0.3) of the control concentration in the presence of 
thapsigargin. This result confirms that ATP-induced release of EAAs from 
cultured Schwann cells depends on intracellular calcium (Figure 2c). 
Taken together, the experiments above showed that application of 100 |iM 
ATP for two minutes induced a two-fold increases in the concentration of 
glutamate released from Schwann cells. This effect of ATP on glutamate release 
was not significantly affected by low Ca2+-EGTA saline (P>0.4). However, both 
50 |iM BAPTA (P<0.005) and 1 |iM thapsigargin (P<0.005) significantly blocked 
ATP-evoked release of glutamate (Figure 3). These data demonstrate that 
extracellular ATP evokes the release of EAAs from cultured Schwann cells by 
activating intracellular calcium stores. 
Figiue 3. Summary of effects of different pretreatment on ATP-evoked 
release of glutamate. 
Application of 100 |4M ATP for two minutes evoked a two-fold increases in 
concentration of glutamate (marked as ATP). Pretreatment of low Ca2+-EGTA 
saline didn't significantly affect this release (marked as EGTA+ATP). However, 
both BAPTA-AM and thapsigargin significantly blocked ATP-evoked glutamate 
release (marked as BAPTA+ATP and THAPSI+ATP, respectively). These data 
suggest that Ca2+ from internal stores is involved in ATP-evoked release of 
glutamate from cultured Schwann cells. (* =P<0.005) 
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Discussion 
In this study, we present data demonstrating that extracellular ATP can 
evoke the release of the excitatory amino acids glutamate and aspartate from 
cultured Schwarm cells. 
It has been shown that neuroglia, including Schwann cells, release 
neurotransmitter. Dermis and Miledi (1974) reported that Schwann cells can 
release acetylcholine following axotomy of motoneurons. Szwatkouski et al. 
(1990) found that depolarization of retinal Miiller cells stimulates the release of 
glutamate. Our previous studies show that the nonapeptide bradykinin can 
evoke the release of glutamate and aspartate from cultured astrocytes (Parpura et 
al., 1994a) and Schwann cells (Parpura et al., 1994b) in a calcium-dependent 
maimer. The present study provides additional evidence that Schwann cells can 
release glutamate and aspartate in response to stimulation of ATP. 
Extracellular ATP can activate specific cell surface receptors, P2-
purinoceptors (Burnstock, 1978). This purinergic receptor is insensitive to 
adenosine, which activates Pi-purinoceptors. We demonstrates that ATP 
significantly induced release of EAAs from Schwann cells, whereas adenosine 
doesn't stimulate the release. Although neither P2-purinoceptors nor Pi-
purinoceptors has ever been identified on the surface of Schwann cells, our data 
suggests that purinergic P2-receptors might be involved ATP-induced release of 
EAAs. 
ATP can cause an increase in intracellular calcium in many cell types. This 
process involves calcium entry across the plasma membrane via receptor-
operated chaimels as well as calcium mobilization from internal stores via 
96 
receptor couplmg to phosphatidylinositol hydrolysis (reviewed by Bumstock, 
1990; Neary and Norenberg,1992). We found that ATP-evoked release of EAAs 
from cultured Schwann cells might result as a functional consequence of 
increases in intracellular calcium. Removing extracellular calcium by using low 
Ca2+-EGTA saline did not significantly affect the release of EAAs from Schwann 
cells. This result indicated that at least Ca2+ influx is not involved in the release. 
In contrast, BAPTA-AM, which can penetrate cell membrane and chelate 
intracellvilar Ca2+, abolished the ATP-evoked release of EAAs. This suggests that 
calcium from internal stores has to be responsible for this release. Thapsigargin, 
which depletes internal calcium stores, also blocked ATP-evoked release of 
EAAs. This result provided more evidence that ATP-induced release of EAAs 
from cultured Schwann cells is dependent upon intracellular calcium. 
It has been shown that extracellular ATP confines its effects to glial cells. ATP 
activating its receptors evoked increases in intracellular calcium in astrocytes 
(Salter and Hicks, 1994). Furthermore, ATP not only evoked changes in astrocytic 
calcium signal, but also in protein phosphorylation and morphology (Neary and 
Norenberg, 1992). Our present study that ATP can induce release of EAAs from 
cultured Schwann cells first demonstrated that extracellular ATP has effects on 
Schwann cells, the glial cells in the peripheral nervous system. There is evidence 
that axon-to-Schwann cell signalling was mediated by neurotransmitter 
glutamate via quisqualate/kainate receptors in the squids (Liebemman et al., 
1989). Our data provides new evidence that extracellular ATP might also serve as 
a mediator in neuron-glia signalling. 
The fimctions of ATP-evoked release of EAAs from Schwann cells are not 
clear. Our recent study demonstrated that release of glutamate from astrocytes 
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mediates the process of astrocyte-neuron signalling (Parpura et al., 1994a). This 
prompts us to propose that the release of EAAs from Schwann cells might play a 
role in glia-neuron signalling in peripheral nervous system. Since ATP can be 
released under physiological and pathological conditions (Neary and Norenberg, 
1992), ATP-evoked release of EAAs from Schwann cells might be involved in 
certain functions of Schwann cells in both situations. 
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CHAPTER 4. GLUTAMATE-MEDIATED ASTROCYTE-NEURON 
SIGNALING 
A paper published in Nature 
Vladimir Parpura, Trent A. Basarsky, Fang Liu, Ksenija Jeftinija, 
Srdija Jeftinija and Philip G. Hay don 
Neurotransmitter released from neurons is known to signal to neighboring 
neurons and glia ^'3. Here we demonstrate an additional signaling pathway in 
which glutamate is released from astrocytes and causes an NMDA (N-methyl-D-
aspartate) receptor-mediated increase in netuonal calcium . Internal calciiun was 
elevated and glutamate release stimidated by application of the neuroligand 
biadykinin to cultured astrocytes. Elevation of astrocyte internal calcium was 
also sufficient to induce glutamate release. To determine whether this released 
glutamate signals to neurons, we studied astrocyte-neuron co-cultures. 
Bradykinin significantly increased calcium levels in neurons co-cultured with 
astrocytes, but not in solitary neurons. The glutamate receptor antagonists D-2-
amino-5-phosphonopentanoic acid and D-glutamylglycine prevented 
bradykinin-induced neuronal calcium elevations. When single astrocytes were 
directly stimulated to increase internal calcium and release glutamate, calcitmi 
levels of adjacent neurons were increased; this increase could be blocked by D-
glutamylglycine. Thus, astrocytes regulate neuronal calciiun levels through the 
calcium-dependent release of glutamate. 
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The release of glutamate from neuron-free cultures of neocortical astrocytes was 
monitored using high-performance liquid chromatography (HPLC). The 
neuroligand bradykinin (100 nM) elevated glutamate levels in the superfusate (n 
= 16; p <0.02, paired t-test; Fig. la). To ask whether internal calcium might play a 
role in glutamate release from astrocytes, we monitored internal calcium levels 
using fura-2. Bradykinin stimulated an elevation of astrocyte calcium levels from 
99 ± 10 to 568 ± 89 nM (mean ± SEM, n = 20; Fig. 2). To determine whether 
elevated internal calcium is sufficient to stimulate glutamate release, we used the 
calcium ionophore ionomycin. Addition of ionomycin (5|iM) in the presence of 
external calcium, but not in its absence, stimulated the release of glutamate from 
astrocytes (Fig. lb). Furthermore, bradykinin did not cause significant glutamate 
release when calcium was removed from the external saline (p > 0.1, paired t-
test). These data demonstrate that bradykinin induces the release of glutamate 
from neocortical astrocytes and that elevated internal calcium can induce 
glutamate release. 
The role of glutamate transporters as mediators of bradykinin-induced glutamate 
release was investigated by using glutamate transport inhibitors. Consistent 
with previous observations p-chloromercuriphenylsulfonic acid (p-CMPS, 50 
fiM) and L-trans-pyrrolidine-2,4-dicarboxylate (PDC, 100 |iM -1 mM) raised the 
basal level of glutamate in the astrocyte superfusate (p < 0.02, Mann-Whitney U-
test 6). Furthermore, neither p-CMPS (Fig. Ic, n = 6) nor PDC (n = 6) impaired 
the ability of bradykinin to stimulate glutamate release from astrocytes. While 
glutamate transporter inhibitors block glutamate uptake it is not known whether 
they also block reversed uptake. Furosemide, an anion transport inhibitor. 
Figure 1. Bradykinin causes calcium-dependent release of glutamate from 
astrocytes. The superfusate from astrocyte cultures was collected at one minute 
intervals and levels of glutamate were measured using HPLC. a) Bradykinin 
(100 i\M) elevates glutamate release from astrocytes (n = 4). b). Addition of 
ionomydn (5|iM) to cultures stimulated glutamate release in calcium contairung 
saline (+ Ca, n = 6), but not in its absence (0 Ca; n = 7). c) The glutamate 
transport inhibitor p-CMPS (50 |iM) raised the basal level of glutamate and 
enhanced the bradykinin-induced elevation of glutamate in superfusate (n = 6). 
These enhancements are presumably due to the inhibition of glutamate uptake, 
d) Furosemide (5 mM) blocks bradykinin-induced release of glutamate (n = 4) 
without significantly affecting bradykinin-induced astrocyte calcium 
mobilization. 
METHODS. Cultures from 1-4 day-old Sprague-Dawely rat cortices were 
enriched in type-1 astrocytes according to the methods of Levison and 
McCarthy 25 and were maintained in a-MEM. These cultures were neuron-free 
as revealed by immunocytochemistry using an antibody directed against the 
sjmaptic protein synaptotagmin (1:250; clone 41.1, provided by R. Jahn). The 
anuno acid content of samples was determined by HPLC with fluorescence 
detection. Prior to injection, aliquots of samples were derivatized with o-
phthalic aldehyde (OPA) 2-mercaptoethanol reagent (Pierce). 
Chromatography was performed on a 15 cm Microsorb-MV HPLC column 
(Raiiun Instrument Co.) using a sodium acetate (pH 5.9) methanol gradient. 
Points represent mean + SEM. Solutions. A modified Ringer's solution used for 
perfusion contained (in mM): NaCl 128, KCl 1.9, KH2PO41.2, CaCl2 2.4, 
MgS041.3, NaHCOs 26, and glucose 10 (pH = 7.4). In 0 Ca solution calcium 
was replaced by 2 mM EGTA. 
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Figture 2. Bradykinin causes a glutamate-mediated elevation of neuronal 
calcium level in neurons co-cultured with astrocytes. Calcium levels in 
neocortical neurons and astrocytes were morutored using fura-2. a) Puffer 
application of bradykinin (1 |iM, 75s) elevated calcium levels of neurons 
(circled) and astrocytes (A). When neurons were cultured alone (b), bradykinin 
did not significantly alter their caldimi levels. In (c) three neurons are shown on 
top of astrocytes in the presence of DGG (ImM). Bradykinin elevated the 
astrocyte calcium levels, but not the level of calcium in adjacent neurons. Color 
scale is a linear pseudocolor representation of [Ca^+Jj shown in the form of the 
ratio of fura-2 emission at 510 nm due to sequential excitation at 350 and 380 
nm. Scale bar, 10 |im. d-e) Time course of astrocyte and neuronal calcium 
responses after addition of bradykinin (BK) in control conditions (d) and in the 
presence of IXjG (1 mM) (e). The astrocyte change in calcium (peak value 
subtracted from resting) induced by bradykinin (469 + 86 nM, n=20; control) 
was not sigruficantly affected by DGG (424 + 45 nM, n=22; Student's t-test, p > 
0.6). In f) the mean bradykinin-evoked calcium accumulations from 
experiments reported in (a-e) are shown, g) Calcium elevations in neurons co-
cultured with astrocytes were moiutored using fluo-3 and confocal microscopy. 
Changes in calcium are represented as AF/Fo. Bradykinin-induced elevations of 
neuronal caldiun were reduced by D-AP5 (50 |iM). Mg2+-deficient medium 
containing glycine (10 |iM) augmented the neuronal calcium response to 
bradykinin, which was significantly reduced by D-AP5 (50 |xM). Furosemide (5 
mM) reduced neuronal calcium elevations in response to bradykinin. Bars 
represent means + SEM (n=18 for each group in g). 
METHODS. Dissociated cultures from visual cortices were prepared using a 
modification of the Heuttner & Baughman procedure 26-28 and were used after 
10-15 days in culture. A monoclonal antibody directed against glial fibrillary 
acidic protein (GFAP, 1:500; ICN Immunobiologicals), showed that glial cells in 
this culture were astrocytes (n=159 of 159 tested). Calcium Imaging, (a-f) Cells 
were loaded with fura-2 AM (2 |iM) and calcium levels were estimated 
according to Basarsky et al. 28 In (g) cells were loaded with fluo-3AM (20 
|ig/mL). 29 Images were acquired using a Noran Odyssey real-time confocal 
nucroscope (Noran). Imaging saline contained (in mM); NaCl 140, KCl 5, 
MgCl2 2, CaCl2 2 and HEPES10 (pH 7.35). In magnesium deficient saline Mg2+ 
was replaced by calcium and glydne (10 ^M) was added. Pharmacological 
agents were bath applied 10 minutes prior to application of bradykinin. 
Cocktail contained D-AP5 (50 |iM), CNQX (10 nM) and L-AP3 (1 mM). Statistical 
analysis. One-way ANOVA followed by Scheffe^'s (f) or Tukey's (g) posf/loc 
comparisons was used. Significance was established at p < 0.05 (*) and p < 0.01 
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reduces the hypo-osmotic induced release of glutamate from astrocytes 7, 
Addition of furosemide (5mM) to cortical astrocytes blocked bradykinin-induced 
release of glutamate (Fig. Id) compared to parallel controls (p < 0.05, Mann-
Whitney U-test) without significantly affecting bradykinin's calcium mobilizing 
action (bradykinin-induced calcium mobilization in furosemide was 714 + 56 nM, 
n = 29 compared to 609 + 107 in control, n=28 nM; p>0.3 Student's t-test). Thus, 
bradykinin mobilizes calcium to stimulate glutamate release, through a 
fiirosemide-sensitive release mechanism. 
To ask whether glutamate released from astrocytes acts on adjacent neurons we 
determined the effect of bradykinin on [Ca^"*"]! in neurons co-cultured with 
astrocytes. Bradykinin elevated neuronal calcium levels only when neurons were 
in contact with astrocytes (Fig. 2). Bradykinin caused a neuronal calcium 
accumulation of 101 + 25 nM (n=25; Fig. 2a, d, f). Following the onset of 
bradykinin application calcium levels were significantly elevated in astrocytes (n = 
20) and neurons (n = 25) after 15 and 50 seconds respectively (Tukey's post hoc, p < 
0.05). When neurons were cultured alone, they did not significantly respond to 
bradykiiun (calcium accumulation of 13 + 2 nM, n=26; Fig. 2b, f). To determine 
whether bradykinin acts directly on neurons to elevate neuronal calcium levels or 
acts indirectly through glutamate released from astrocytes, we added a broad 
spectrum glutamate receptor antagonist D-glutamylglycine 8 (DGG). DGG (1 mM) 
significantly reduced the bradykinin-induced calcium accumulation in neurons to 
15 + 2 nM (n=31) as compared to 101 + 25 nM in parallel cultures (Fig. 2c, e, f) 
without altering the astrocyte response to bradykinin (Fig. 2e). Subsequently DGG 
was washed out of the bath and glutamate was applied to neurons to determine 
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whether glutamate receptors were present. Direct application of glutamate (100 
laM) elevated internal calcium in each category of neurons shown in figure 2a, f 
(neurons and glia, solitary neurons and neurons and glia that had previously been 
exposed to DGG). These responses were not significantly different from one 
another (Scheffe^'s post hoc comparison 9), These data suggest that bradykinin 
elevates neuronal calcium by the action of glutamate, which is released from 
astrocytes in response to bradykinin. 
To critically determine whether bradykinin causes a neuronal change in calcium 
level and to further study receptor pharmacology we used confocal microscopy. 
Co-cultures of astrocytes and neurons were loaded with fluo-3 and the fluorescent 
emission at the plane of neuronal somata was monitored. Bradykinin reliably 
elevated neuronal calcium in astrocyte-neuron co-cultures (Fig. 2g). Addition of 
the N-methyl-D-aspartate (NMDA) receptor antagonist D-2-amino-5-
phosphonopentanoic acid (D-AP5,50 ^ M), but not 6-cyano-7-nitroquinoxaline-2,3 
dione (CNQX, 10 ^M) or L-2-amino-3-phosphonopropionic acid (L-AP3, ImM), 
significantly reduced bradykinin-induced neuronal calcium elevation (Fig. 2g). 
Consistent with a role for NMDA receptors in mediating the action of released 
glutamate, removal of external Mg2+ and addition of glycine (10 |iM) significantly 
augmented the bradykinin-induced neuronal calcium elevation (Fig. 2g). 
HPLC data demonstrated that furosemide blocks bradykinin-induced glutamate 
release from astrocytes (Fig. 1). If glutamate released from astrocytes signals to 
adjacent neurons then furosemide should block this intercellular signaling 
pathway. Furosemide (5mM) significantly reduced the ability of bradykinin to 
I l l  
elevate neuronal calcium levels by 84 % (Fig. 2g) and reduced the neuronal calcium 
elevation in response to focally applied glutamate (100 mM) by 43% (n = 25; p< 
0.001, Student's t-test). Since furosemide blocks bradykiiun-induced glutamate 
release from astrocytes and reduces glutamate-induced neuronal calcium 
mobilization, the sensitivity of the bradykinin-induced neuronal calcium elevation 
to furosemide is consistent vwth glutamate mediating astrocyte-neuron signaling. 
Since calcium elevations in astrocytes stimulate glutamate release we used two 
methods which directly raise calcium in astrocytes and asked whether there was a 
consequent elevation in neuronal calcium. First, tapping astrocytes with 
micropipettes elevated astrocyte calcium levels and significantly raised neuronal 
calcium levels (AF/Fo = 62 ± 25 %, n = 6; p < 0.005, Mann-Whitney U-test). 
Second, we photo-stimulated astrocytes to elevate their calcium levels A 
portion of a single astrocyte was exposed to focal UV light. Photo-stimulation 
reliably elevated astrocyte calcium levels (AF/Fo = 202 + 19 %, n=7), which then 
spread to adjacent astrocytes (Fig. 3). When astrocytes were photo-stimulated, the 
calcium levels of neurons in contact with astrocytes also increased (Fig. 4). Photo-
stimulation of astrocytes caused a maximal increase in neuronal AF/Fo by 81 + 20 
% (n= 15) which was not significantly altered by addition of tetrodotoxin (1 |iM; 
AF/Fo = 57 + 6 %, n=15; p>0.25, Scheffee's test) to the medium. However, addition 
of the glutamate receptor antagonist DGG significantly reduced the astrocyte-
induced elevation of calcium in adjacent neurons (AF/Fo = 14 + 4 %, n=15; p<0.01, 
Scheffee's test; Fig. 4). 
Figtire 3. Photo-stimulation of a single astrocyte causes an increase in [Ca2+]i 
in an astrocyte (A) network. An astrocyte in (a) was exposed to UV light (2 min) 
from a Xenon arc lamp which caused a sustained increase in [Ca2+]j in this cell 
and in unstimulated neighbors (b). A circled lightning bolt represents the 
location and diameter of UV exposure. Photo-stimulation elevated calciimi for 
several minutes in all astrocytes in the field of interest without affecting their 
morphology or causing a leakage of cytoplasmic components, as judged by the 
maintenance of the calcium indicator fluo-3. Summary of data is shown in (c). 
Color scale indicates linear pseudocolor representation of fluorescence intensity 
ranging from 0 to 200 units. Points represent mean + SEM (n=7 for stimulated, 
and n=15 for control group). Scale bar, 10 jim. 
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Figure 4. Photo-slimulation of astrocytes causes an increase of [Ca2+]j in adjacent unstimulated neurons due to 
the action of glutamate. Images represent calcium levels in the confocal plane of the neuronal body before (a) and 
after (b) UV stimulation of a single astrocyte. After stimulation, [Ca2+]j increased both in astrocytes (A) and in the 
neuron (N). The increase in neuronal calcium is not due to a direct action of UV exposure, because neuronal 
processes (arrov^s, c) were not in the path of UV excitation (circled lightning bolt), c) Microinjection of 
sulforhodamine 101 (10 mM) into individual neurons (n = 8) confirmed that fluo-3 revealed the full extent of 
neuronal processes. In control experiments (n=6) we gradually moved the photo-stimulus closer to an isolated cell 
and determined that calcium levels were only elevated when the stimulus was within less than 5 |im from the cell 
border. Neurites were always greater than 11 |im from the edge of the photo-stimulus and thus were not directly 
activated by this stimulus. The image in (c) was acquired at the end of the experiment at the level of astrocytes 
and neuronal processes. The time course of [Ca^+Jj changes in neurons due to photo-stimulation (PS) of astrocytes 
is shown in (d). The presence of DGG (1 mM), but not tetrodotoxin (TTX, 1 (iM) greatly reduced the neuronal 
response. Color scale for (a) and (b) indicates linear pseudocolor representation of fluorescence intensity ranging 
from 0 to 160 units. Points represent means ± SEM (n=15 for each group). Scale bar, 10 ^m. 
METHODS. TTX (1 |iM) and DGG (1 mM) were uniformly applied to the bath by saline exchange 10-20 minutes 
prior to UV stimulation. 
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This study demonstrates that a neuroligand, bradykinin, causes the calcium-
dependent release of the neurotransmitter glutamate from neocortical astrocytes. 
The calcium-dependent glutamate release mechanism of astrocytes is likely to be 
distinct from neuronal release mechanisms since we found that astrocytes are not 
immimoreactive for the calcium-sensitive vesicle protein synaptotagmin. Using 
three distinct stimuli which each elevate astrocyte calcium levels ODradykinin, 
tapping astrocytes with micropipettes and direct astrocyte photo-stimulation) we 
demonstrate that astrocytes can cause a glutamate-dependent elevation of 
neuronal calcium. These data point to a novel form of transmitter signaling in the 
nervous system in which stimuli that mobilize calcium in astrocytes cause a 
caldum-dependent release of the excitatory amino acid glutamate, that can then 
act on adjacent neurons. It is possible that other pathways, such as gap junctions 
^2, also contribute to astrocyte-neuron signaling. However, since gap-junction 
uncoupling agents such as octanol have many additional actions 13-15 which 
include a reduction of calcium influx through the NMDA receptor ^3 we have not 
tested this possibility. Glutamate released at synaptic terminals can trigger 
calcium waves in an astrocyte network 1. Since many neurotransmitters can 
mobilize glial calcium ^0/16-22^ jg possible that neurons stimulate neighboring 
astrocytes to release glutamate, which in turn signals back to the neuron. In this 
case astrocytes could be considered as an integral computational element within 
the brain. In addition to mediating fast sjoiaptic transmission, glutamate serves a 
role in synaptic plasticity 23^ and under conditions of excessive release, can cause 
neuronal damage and degeneration 24. jhis raises the possibility that astrocyte-
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mediated glutamate release plays an important role in regulating neuronal 
physiology and pathology. 
References 
1. Dani, J. W., Chernjavsky, A. & Smith, S. J. Neuron 8,429-440 (1992). 
2. Murphy, T. H., Blatter, L.A., Wier, W.G. & Baraban, J.M. /. Neurosci. 13 
2672-2679 (1993). 
3. Mennerick, S. & Zorumski, C.F. Nature 368,59-62 (1994). 
4. Balcar, V. J. & Johnston, G. A. R. /. Neurochem. 19,2657-2666 (1972). 
5. Isaacson, J. S. & NicoU, R. A. /. Neurophysiol. 70,2187-2191(1993). 
6. Sokal, R. R. & Rohlf, F. J. In: Biometry (ed. Wilson, J.) pp 400-453 (W. H. 
Freeman & Co., New York, 1981). 
7. Kimelberg, H. K., Goderire, S. K., Higman, S. Pang, S. & Waniewski, R. A. /. 
Neurosci. 10,1583-1591 (1990). 
8. Jones, A. W., Smith, D. A. S. & Watkins, J. C. Neuroscience 13,573-581 
(1984). 
9. Scheffee, H. Biometrika 40,87-104 (1953). 
10. Charles, A. C., Merrill, J. E., Dirksen, E. R. & Sanderson, M. J. Neuron 6, 
983-992(1991). 
11. Guthrie, P. B., Segal, M. & Kater, S. B. Nature 354,76-80 (1991). 
12. Nedergaard, M. Science 263,1768-1771 (1994). 
13. McLamon, J. G., Wong, J. H. & Sawyer, D. Can. J. Physiol. Pharmacol. 69, 
1422-1427(1991). 
14. Triggle, D. J. et. al Ann. N. Y. Acad. Sci. 635,123-138 (1991). 
118 
15. Ma, J., Fill, M., Knudson, M. C., Campbell, K. P. & Coronado, R. Science 
242,99-102(1988). 
16. Reiser, G., Doni6, F. & BinmoUer, F.-J. /. Cell Sci. 93,545-555 (1989). 
17. Cornell-Bell, A. H., Finkbeiner, S. M., Cooper, M. S. & Smith, S. J. Science 
247,470-473(1990). 
18. Glaum, S. R., Holzwarth, J. A. & Miller, R. J. Proc. Natl. Acad. Sci. USA 
87,3454-3458(1990). 
19. Cornell-Bell, A. H.& Finkbeiner, S. M. Ce//Cfl/ciMm 12,185-204(1991). 
20. Inagaki, N., Fukui, H., Ito, S. & Wada, H. Neurosci.Lett. 128,257-260 (1991). 
21. Jensen, A. M. & Chiu, S. Y. J. Neurosci. 11,1674-1684 (1991). 
22. McCarthy, K. D. & Salm, A. K. Neuroscience 41,325-333 (1991). 
23. Malgaroli, A. & Tsien, R. W. Nafure 357,134-139(1992). 
24. Choi, D. W. Neuron 1,623-634 (1988). 
25. Levison, S.W., & McCarthy, K.D. In: Culturing Nerve Cells (eds. Banker, G. 
& Goslin, K.) pp 309 - 336 (The MIT Press, Cambridge Mass, USA, 1991). 
26. Heuttner, J. E. & Baughman, R. W. /. Neurosci. 6,3044-3060 (1986). 
27. Parpura, V., Haydon, P. G. & Henderson, E. /. Cell Sci. 104,427-433 (1993). 
28. Basarsky, T.A., Parpura, V. & Haydon, P. G. J. Neurosci. In press 
29. Kao, J. P. Y., Hartootunian, A. T. & Tsien, R. Y. /. Biol. Chem. 14,8179-8184 
(1989). 
119 
GENERAL CONCLUSION 
It has become dear that the excitatory amii\o acids glutamate and aspartate 
do not confine their excitatory effects to nerve cells, but also interact with glial 
cells. The objectives of this dissertation are to elucidate effects of neuroligand 
capsaicin on cultured peptidergic sensory neurons and to determine whether 
neuroligands such as bradykinin (BK) and adenosine 5'-triphosphate (ATP) can 
stimulate release of EAAs from cultured glial ceils as well as to identify the 
possible signal transduction pathways for the neuroligand-induced release of 
EAAs. 
Summary 
Effects of capsaicin and resiniferatoxin on peptidergic neurons in cultured 
dorsal root ganglion 
The purpose of the first study was to provide evidence of the long lasting 
effect of capsaicin and its ultrapotent analog resiniferatoxin (RTX) on sensory 
peptidergic neurons maintained in organotypic cultures. The effects of the two 
irritants were examined on neurons that contained substance P (SP) and 
calcitonin gene-related peptide (CGRP). Exposure of the cultures to 10|iM 
capsaicin and lOOnM RTX for periods of 2 days or longer resulted in almost 
complete elimination of SP-immunoreactive (IR) neurites and reduction, but not 
elimination, of CGRP-IR neurites. In addition, both lO^iM capsaicin and lOOnM 
RTX significantly reduced the number of SP- and CGRP-IR cell bodies within 
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DRG explants. Capsaicin in lOO^M concentration produced complete 
elimination of SP-IR fibers and a great decrease in the number of CGRP-IR fibers, 
but failed to completely eliminate IR cell bodies. Exposure of the cultures to the 
irritants in the same concentrations for 90 min did not produce a measurable 
effect on SP- or CGRP-IR in neurites or cell bodies. It is important to establish 
that the effect of capsaicin and RTX on cultured neurons was of long duration 
(longer than 4 days) and is therefore different from depletion of peptides. 
The neurotoxic effect of capsaicin has been shown to be selective on a 
subpopulation of small dorsal root ganglion neurons in newborn animals. Our 
findings demonstrate that processes of cultured sensory neurons are much more 
sensitive to capsaicin and RTX than cell bodies. Furthermore, these results show 
that SP-IR neuronal elements are more sensitive to capsaicin than CGRP-IR 
elements. Our data suggest that cultured sensory neurons express the functional 
properties of differentiated sensory neurons in vivo. 
Neuroligand-evoked calcium-dependent release of excitatory amino acids from 
Schwann cells 
This study deals with release of neurotransmitter from Schwann cells 
obtained from cultured rat DRGs. We found that neither capsaicin nor high 
potassium can stimulate the release of EAAs from Schwann cells. However, BK 
(lOnM) caused significant release of glutamate and aspartate from cultured 
Schwann cells together with an increase in the cytoplasmic level of free calcium. 
BK-induced release of glutamate and the increase of the cytoplasmic calcium are 
receptor-mediated. Pretreatment with the BK receptor antagonist. 
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(D-Arg®, Hyp3, b-Thi^'®, D-Phe'')-bradykinin (5|iM), blocked glutamate release 
ar\d calcium inaease evoked by BK. Although BK still stimulated release of 
glutamate without extracellular calcium, this effect was abolished by 
pretreatment with the membrane permeant calcium chelator BAPTA-AM 
[l,2bis(2-aminophenoxy) ethane-N,N,N',N'-tetraceticacid, acetoxymethyl ester, 
50|iM]. Perturbations which inhibited BK-induced calcium mobilization 
prevented the release of EAAs from Schwarm cells. The calcium ionophore 
ionomycin (5|iM) significantly increased the concentration of glutamate in glial 
cultures. The increase of glutamate induced by ionomycin was abolished by low 
Ca2+-EGTA saline. These results prove that calcium mobilization is both 
necessary and sufficient for stimulating the release of EAAs from Schwann cells. 
To answer the question whether BK-induced increase of glutamate is due to the 
reversal uptake of glutamate, we used the glutamate transport blocker p-
chloromercuriphenylsulphonic acid (p-CMPS, SO^iM). Although p-CMPS 
elevated the basal concentration of glutamate, it didn't block the release of 
glutamate evoked by BK. The anion inhibitor furosemide (5mM) significantly 
attenuated the ability of the second application of BK to mobilize calcium. 
Furthermore, furosemide abolished the BK-induced release of glutamate from 
Schwann cells. To test whether the release of EAAs is through the mechanism of 
BK-induced cell swelling, we measured the volume of the Schwann cell and 
found that BK didn't cause cell swelling. Taken together, these data prove that 
the neuroligand BK can induce release of EAAs from Schwann cells. The 
mechanism of BK-induced release of EAAs is neither due to the reversal of the 
glutamate transporter nor volume regulated release mechanism. BK evokes EAA 
release by mobilizing calcium from intracellular calcium stores. 
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ATP-evoked Ca2+-dependent release of excitatory amino acids from cultiired 
Schwann cells 
The specific objective of this study was to determine the mechanism by which 
ATP evokes release of EAAs from cultured Schwann cells. Basal concentrations of 
aspartate and glutamate in Schwann cell cultures were 7.64±0.74 nM (mean+SEM) 
and 30.52±3.89 r\M, respectively. Perfusion application of lOOjiM ATP for 2 
minutes to cultured Schwann glia resulted in an 201±28 % increase of aspartate 
and 203±15 % increase of glutamate. A second applications of ATP 10 minutes 
after the first application similarly caused EAA release, although the magnitude of 
this response was attenuated. Application of ATP to glia for ten minutes resulted 
in a peak increase in the release followed by a decline to a plateau significantly 
higher than baseline release. Bath application of adenosine (100|iM) was without 
effect on the release of EAAs suggesting involvement of P2 receptors. The release 
of EAAs evoked by ATP was not abolished in low Ca2+-EGTA saline. 
Pretreatment of the glial cultures with 50|iM BAPTA-AM abolished the effect of 
ATP. Thapsigargin (IjiM), an inhibitor of Ca^+'ATPase or the Ca2+ pump of 
internal stores, significantly reduced the release of EAAs evoked by ATP. Our 
results show that ATP evokes the release of EAAs from cultured Schwann cells by 
activating intracellular calcium stores. 
Glutamate-mediated astrocyte-neiuron signalling 
The last study focused on glutamate-mediated astrocyte-neuron signaling. 
Neurotransmitter released from neurons is known to signal to neighboring 
neurons and glia. We demonstrate an additional signaling pathway in which 
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glutamate is released from astrocytes and causes an NMD A receptor-mediated 
neuronal calcium elevation. Application of the neuroligand bradykinin to cultured 
astrocytes elevated internal calcium and stimulated glutamate release. Elevation 
of astrocytic internal calcium was also sufficient to induce glutamate release. To 
determine whether this released glutamate signals to neurons, we studied 
astrocyte-neuron co-cultures. Bradykinin significantly elevated calcium levels in 
the neurons co-cultured with astrocytes, but not in solitary neurons. The 
glutamate receptor antagonists, D-2-amino-5-phosphonopentanoic acid and D-
glutamylglycine, prevented bradykinin-induced neuronal calcium elevations. 
When single astrocytes were directly stimulated to increase internal calcium, and 
release glutamate, calcium levels of adjacent neurons were increased, this increase 
could be blocked by D-glutamylglycine. Thus, astrocytes regulate neuronal 
calcium levels through the calcium-dependent release of glutamate. 
Discussion 
The studies in this dissertation demonstrate that the neuroligands can induce 
release of EAAs from cultured glial cells. 
There are three different mechanisms proposed for increase of extracellular 
glutamate. One of them is the calcium dependency of glutamate release (Nicholls 
and Sihra, 1986), which appears to be due to the exocytosis of synaptic vesicles; 
The second one is reversal of uptake of glutamate (Miller and Schwartz, 1983); 
Furosemide-sensitive release of glutamate from swelling cells is the third proposed 
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mechanism (Kimelberg and Ransom, 1986). According to our studies, calcium 
plays an important role in the neuroligand-induced release of EAAs. 
Release of EAAs evoked by BK or ATP from Schwaim cells depends on 
intracellular Ca^ '*' 
Internal calcium appears to be responsible for BK- or ATP-induced release of 
EAAs from cultured glial cells. As we know, there are two intracellular stores 
(Hardie, 1991). One is IPs-sensitive calcium store and the other one is caffeine-
ser\sitive store. Which Ca2+ store is involved in release of EAAs? On the basis of 
the fact that caffeine doesn't induce any release of EAAs at all and ryanodine fails 
to block BK-induced release, we infer that IPs-sensitive Ca2+ stores must be 
responsible for the EAA release. Furthermore, the involvement of the IPs-sensitive 
Ca2+ store is confirmed by the result that pretreatment of phospholipase C 
inhibitor (IJ73122,8|iM) significantly blocks the BK-induced release of EAAs (our 
unpublished data). 
There is no evidence yet that glial cells contain synaptic vesicles. It has been 
suggested that glia might release neurotransmitters by Ca2+ independent carrier 
mechanisms. A recurrent suggestion is that the release might be mediated by the 
reverse operation of electrogenic neurotransmitter carrier protein, which normally 
function to take up neurotransmitters (reviewed by Barres, 1991). Although there is 
evidence that glia release neurotransmitters by "reversed uptakes" in special 
experimental conditions (Schwartz, 1987) and under physiological conditions 
(Barbour, 1987; Szatkowski et al., 1990), this "Ca2+-independent release" theory is 
challenged now. We demonstrated that elevated intracellular Ca2+ is necessary and 
sufficient for release of EAAs from glial cells. Our data suggest that there might be 
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a novel neurotransmitter release mechanism for glial cells. The release of EAAs 
from glia probably reflects a Ca2+-dependent vesicle exocytosis process. However, 
this process has to be different from the exocytosis which occurs at nerve 
terminals, since glial lack typical structure of synapses - the focal active zone 
(reviewed by Smith, 1994) and also lack immunoreactivity to synaptic vesicle 
proteins such as synaptotagmin, synaptophysin and synaptobrevin (our 
unpublished data). 
Release of glutamate from astrocytes plays a key role in glia-neuron signalling 
Although a glia-neural signalling theory of brain function was proposed thirty 
years ago (Galambos, 1961), it has only recently received much attention. Our 
studies give new evidence that glial cells (astrocytes) indeed signal to neurons and 
the neurotransmitter glutamate released from the glial cells plays a key role in this 
process. 
Our data show that neuroligand BK induced elevated free Ca2+ in purified 
astrocyte cultures, but not in neuron cultures. However, BK caused an intracellular 
Ca2+ increase in both astrocytes and neurons when it was applied to co-cultures of 
the neurons and the astrocytes. This result strongly suggests signalling from 
astrocyte to neuron. The next question is how a astrocyte could signal to a neuron. 
We found that BK greatly evoked release of glutamate from cultured neuron-free 
astrocytes. Furthermore, D-2-amino-5-phosphonopentanoic acid, the glutamate 
receptor antagonist, effectively blocked the astrocyte-neuron signalling. Taken 
these evidence together, we conclude that neurotransmitter glutamate plays a key 
role in glia-neuron signalling. 
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Nedergaard (1994) provides similar evidence for astrocyte-neuron signalling. 
However, he indicates that gap-junctions might mediate the astrocyte-neuron 
signalling. The reasons that there are tv/o different mechanisms for astrocyte-
neuron signalling may be due to gap-junctions functioning under some specific co-
culture conditions or with some combination of neuronal or astrocytic sub-types, 
but the glutamate-mediated mechanism predominating in other circumstances 
(Smith, 1994). 
The function of glia-neuron signalling is not clear yet. On the basis of the 
available information, one would expect that glia-neuron signalling might 
participate modulation of brain functions such as mood, motivational state, arousal 
and learning and memory. 
Is neuroligand-evoked release of EAAs involved in neurodegenerative 
disorders? 
Excessive glutamate is toxic to neurons. Exposed to glutamate for even a few 
minutes, neurons undergo a degenerative process leading to cell death (Teichberg, 
1991). The toxic effect of glutamate may be involved in acute and chronic 
neurodegenerative disorders. It has been shown that considerate endogenous 
glutamate can be released into the extracellular space after cerebral ischemia and 
trauma (Benveniste et al., 1987, Katayama et al., 1988). NMDA antagonist can 
protect against hypoxic/ischemic brain damage in vivo (Gill et al., 1987; Park et al., 
1987; Kochhar et al., 1988). There is also some evidence which implicates that EAA 
neurotoxity may be a factor in chronic degenerative diseases such as Huntington's 
disease, Alzheimer's disease and Parkinsonism (reviewed by Olney, 1990 and 
Choi, 1988). 
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The studies in this dissertation deal with neuroligand-induced release of 
EAAs. It has been shown that the neuroligand BK is released from its precursors 
in response to trauma, anoxia and inflammation (Dray and Perkins, 1993) and 
higher extracellular levels of ATP may be released following tissue injury (Neary 
and Norenbery, 1992). Although it is not clear what effects that BK- or ATP-
induced EAA release from glia would have on CNS under centain pathological 
condition, the present information hints that neuroligand-induced release of EAAs 
might potentiate a pathological state associated with brain damage. Furthermore, 
utilizing certain neuroligand antagonists, which block the release of EAAs, might 
attenuate the pathological state. 
Conclusion 
This dissertation focuses on elucidating the mechanism of neuroligand-evoked 
release of EAAs. Our studies have demonstrated that the EAA release appears to 
be in a Ca2+-dependent manner. We have showed, at least in part, the signal 
pathways of release of EAAs. However, there is still a gap left. Further 
investigation is needed to explore how Ca2+ triggers EAA release from glia, which 
lack synaptic vesicles. 
As we know, release of EAAs plays an important role in neuron-neuron 
signalling. However, there is increasing evidence that the release of EAAs is 
actively involved in the signalling processes between neuron and glia. Although it 
is not clear what functions these signalling processes serve, they deserve further 
study. 
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